Fission yeast RPA–TERT–Tpz1TPP1 complex promotes telomere extension and suppresses telomere recombination Authors: Bettina A. Moser, Madeline Points, Sourav Agrawal, Adam C. Didier, Amanda K. Mennie, Ci Ji Lim, Yong-jie Xu, Toru M. Nakamura, Geraldine Butler, Soni Lacefield, Geraldine Butler, Soni Lacefield, Geraldine Butler, Soni Lacefield Published: 2026 ABSTRACT Telomerase maintains chromosome ends by extending telomeric DNA, yet how recruited telomerase becomes productively engaged remains poorly understood. Recent studies found that Replication Protein A (RPA) contributes to telomerase stimulation through interaction with TERT in humans and with the TPP1 ortholog Est3 in budding yeast, suggesting a direct role in telomerase activation. Here, we provide genetic and structural modeling evidence for a RPA-Trt1TERT-Tpz1TPP1 ternary complex that promotes telomere extension while suppressing recombination in fission yeast. Guided by results from genetic screen, followed by AlphaFold3 modeling and systematic mutagenesis of RPA, Trt1, and Tpz1, we identify four key interfaces supporting telomerase function: Ssb1RPA1-Trt1, Ssb2RPA2-Trt1, Ssb2RPA2-Tpz1, and the TEL-patch-mediated Trt1-Tpz1 interaction. Notably, Tpz1-R81, previously assigned as the TEL patch, instead contacts Ssb2 in the complex. Epistasis and suppressor analyses indicate that the newly identified RPA-Trt1 and RPA-Tpz1 interfaces collaborate with the Trt1-Tpz1 interface to allow telomerase activation after recruitment. Furthermore, comparative analyses using AlphaFold3 suggest that these interactions are likely conserved in budding yeast and humans. Collectively, these findings support a model in which RPA serves as an essential component of the active telomerase complex, coordinating TERT and TPP1-like factors to enable productive telomerase engagement. Introduction Telomeres, the ends of linear chromosomes, consist of G-rich repetitive double-stranded DNA (dsDNA) terminating in a 3’ single-stranded overhang (G-tail). Telomerase, composed of the catalytic subunit TERT, an associated RNA template, and multiple additional regulatory and structural subunits, extends this overhang by synthesizing telomeric repeats to overcome the end-replication problem [1,2]. In fission yeast Schizosaccharomyces pombe, telomere protection and telomerase regulation are mediated by a conserved shelterin complex consisting of the dsDNA-binding protein Taz1 (TRF1/TRF2 homolog), the G-overhang-binding protein Pot1, and the bridging components Rap1, Poz1 (TIN2 homolog), Tpz1 (TPP1 ortholog), and Ccq1 [3–5]. Telomerase recruitment to chromosome ends depends on Ccq1, whose phosphorylation at T93 by the checkpoint kinases Rad3ATR and Tel1ATM promotes interaction with the telomerase subunit Est1 [6,7]. Tpz1TPP1 plays dual roles in telomerase regulation. First, conserved TEL-patch residues promote telomerase activity. For example, the tpz1-K75A mutant maintains only very short telomeres despite increased Trt1 recruitment, suggesting a defect in telomerase activation after recruitment [8]. Another proposed TEL-patch mutant, tpz1-R81E, completely loses telomeres and has been reported to impair telomerase recruitment [9]. Secondly, Tpz1 is SUMOylated at K242, a modification that negatively regulates telomerase recruitment [10,11]. Together with a conserved SWSSS motif, the K242 SUMOylation promotes interaction with the Stn1–Ten1–Polα complex to facilitate C-strand synthesis, thereby limiting Replication Protein A (RPA) binding, Rad3ATR signaling, and telomerase association at telomeres [12]. Telomere DNA replication is tightly coordinated with the regulation of the shelterin and Stn1–Ten1–Polα complexes. As replication forks progress through telomeric DNA, exposed ssDNA is first bound by RPA [13,14]. RPA is an abundant heterotrimeric ssDNA-binding complex consisting of RPA1/RPA70, RPA2/RPA32, and RPA3/RPA14 that resolves secondary DNA structures during DNA replication and repair. It interacts directly with multiple DNA damage response factors, including the checkpoint kinase ATR [15,16]. At telomeres, RPA is subsequently replaced by POT1, and this transition is essential for suppressing checkpoint-mediated cell-cycle arrest and promoting CST (CTC1–STN1–TEN1)–Polα function [13,17–19]. Because RPA transiently occupies the telomeric ssDNA prior to POT1 loading, it is uniquely positioned to coordinate ATR-dependent signaling and telomerase action at chromosome ends. RPA binds ssDNA through four oligosaccharide-binding (OB)-fold domains (DBD-A, -B, and -C of RPA1 and DBD-D of RPA2) [15,20]. Mutations in Rfa1RPA1 and Rfa2RPA2 cause substantial telomere shortening and replicative senescence in budding yeast Saccharomyces cerevisiae [21,22], while mutations in human RPA1 and RPA2 are associated with telomere shortening and premature aging [23–25]. Recent studies have begun to explain these observations: human RPA stimulates telomerase processivity through a direct RPA2–TERT interaction [26], and budding yeast RPA2 interacts with the TPP1 ortholog Est3 to regulate telomerase activity [22]. These findings parallel the role of the telomerase-specific RPA-like TEB (Teb1–Teb2–Teb3) complex in Tetrahymena [27,28]. However, it remained unclear whether canonical RPA functions equivalently to the telomerase-specific TEB complex in Tetrahymena by simultaneously forming a functional complex with both TERT and TPP1 orthologs. In fission yeast, only a single mutation in RPA1, ssb1-D223Y, has been reported to cause telomere shortening [29]. However, this mutation substantially reduces Ssb1 protein levels [30], making it difficult to distinguish telomere-specific defects from broader consequences of limiting the essential ssDNA-binding factor Ssb1. Here, we identify multiple mutations in Ssb1RPA1 and Ssb2RPA2 that cause severe telomere shortening or complete telomere loss without substantially reducing protein levels. Guided by AlphaFold3 structural predictions [31], we provide genetic evidence for a functional RPA–Trt1–Tpz1 complex at fission yeast telomeres. Our analyses indicate that the predicted Ssb1RPA1–Trt1TERT, Ssb2RPA2–Trt1TERT, Ssb2RPA2–Tpz1TPP1, and TEL-patch-mediated Trt1TERT–Tpz1TPP1 interfaces make partially redundant yet essential contributions to telomerase activation and telomere extension while suppressing telomere recombination. We further provide evidence for functional conservation of the Rfa1RPA1–Est2TERT interface in budding yeast and the RPA1-TERT interface in humans, and reinterpret earlier mutational studies in the context of conserved RPA–TERT–TPP1-like regulatory complexes in both budding yeast and humans. Collectively, these findings identify the RPA–Trt1–Tpz1 ternary complex as a functional module that promotes telomerase activation by facilitating access of the telomeric 3’ end to the TERT catalytic center while suppressing telomere recombination. Results Ssb1RPA1 mutations reveal residues critical for telomere maintenance We previously reported 25 mutants of Ssb1, the largest subunit of RPA in fission yeast, that are sensitive to the genotoxins hydroxyurea (HU) and/or methyl methane sulfonate (MMS) [30]. To determine whether any of these mutations also affect telomere maintenance, we examined telomere length by Southern blot analysis (S1A Fig). This analysis identified eight mutants (ssb1–1, 2, 7–11, and 13) with very short telomeres (S1B-S1C Fig). Two of these mutants, ssb1–2 (D223Y) and ssb1–7 (R11C-C69S-D223N), exhibited substantially reduced Ssb1 protein expression, similar to the budding yeast equivalent rfa1-D228Y [32]. Nevertheless, prior work indicates that mutations at D223 itself are likely causative for telomere shortening [29,33,34]. It should also be noted that there are other mutant alleles (ssb1–4, 18, and 23) that caused substantial reduction in Ssb1 protein levels but showed only moderate to no reduction in telomere length (S1C Fig). Among all mutants analyzed, ssb1–12 (W523C) showed the most severe telomere phenotype. Despite near wild-type (wt) Ssb1 protein expression and robust cell growth [30], this mutant completely lost telomeres (S1B Fig), suggesting the formation of circular chromosome survivors [35]. To confirm this phenotype, we integrated W523C, W523A, or W523S at the endogenous ssb1 locus (Figs 1A-1B and S2A) and immediately introduced a ssb1+ plasmid to prevent telomere loss during strain construction. After subsequent loss of the plasmid, all three alleles showed similar early telomere shortening followed by complete telomere loss after further outgrowth (Fig 1B). These results establish that W523 is essential for telomere maintenance in fission yeast. On the other hand, since only circular chromosome survivors, but not earlier-generation cells with linear chromosomes, showed severe sensitivity to MMS, HU, or Camptothecin (CPT), ssb1-W523C does not appear to have a major impact on general DNA damage repair or checkpoint functions of the RPA complex (S4A Fig). Ssb1 mutants with severe telomere maintenance defects. (A) Schematic representation of fission yeast Ssb1/Rpa1 showing the N-terminal OB-Fold domain (OB-F), DNA-Binding-Domains A-C (DBD-A, -B, -C), and the location of mutated residues for integrated mutants. The region represented in the X-ray structure from U. maydis RPA, shown in (E), is indicated below. (B) Telomere length analysis by Southern blot of ssb1-W523 mutant strains in the presence or after loss of a ssb1+ plasmid. (C) Telomere length analysis of the indicated ssb1 mutant strains. All strains were extensively restreaked to obtain terminal telomere phenotypes. Southern blot analysis for additional independently generated and restreaked ssb1 mutant strains is shown in S2B Fig. (D) Trt1 binding to telomeres in the indicated ssb1 mutant strains, analyzed by Trt1-myc ChIP (top), with corresponding telomere length analysis of the strains used for ChIP (bottom). Statistical significance was assessed by ANOVA with Dunnett’s comparison test (*P ≤ 0.05; **P ≤ 0.01). See S1 Data for individual % IP values and additional statistical analysis. (E) X-ray structure of U. maydis RPA bound to ssDNA [38], labeled using fission yeast nomenclature. Positions of Ssb1 residues analyzed in this study, as well as additional residues of interest, are indicated. Because the ssb1+ plasmid allows W523C cells to maintain wt-length telomeres, we used this system to identify the causative single-site mutations within several multi-missense alleles. We focused on ssb1–1, 8, 10, 11, and 13 because these alleles maintain near-wt Ssb1 protein expression [30] (S1B Fig). Plasmid-based complementation analysis revealed that L355P, Y474N, C482S, and K484E cause severe telomere shortening, while Y264H and K497E cause milder shortening (S1D Fig). We also tested fission yeast equivalents of human RPA1 mutations associated with telomere shortening, namely V227A, E240K, and T270A [24]. In Ssb1, these correspond to L222A, D235K, and T265A, respectively (S3A Fig). In the plasmid assay, L222A caused modest telomere shortening, whereas T265A, despite being adjacent to Y264, had no detectable effect on telomere length (S1E Fig). D235K also did not cause telomere shortening (S1E Fig). Interestingly, budding yeast rfa1-F269L (Y264Ssb1/F269RPA1) and rfa1-L227S (L222Ssb1/V227RPA1) mutations (S3A Fig) hardly affected telomere length on their own but promoted HR-dependent survivor generation in telomerase RNA mutant tlc1∆ and suppressed temperature sensitivity of cdc13–1 [36,37]. Single-site mutations that caused short telomeres in the plasmid assay were then integrated at the endogenous ssb1 locus (S2A Fig). Western blot analysis revealed near-wt expression of all mutant proteins except L355P, which showed a slight reduction like ssb1–8 (R330S-L355P) (S2C Fig). Consistent with the plasmid assay, L355P, Y474N, C482S, and K484E caused very short telomeres, whereas L222A and Y264H caused moderate shortening (Figs 1C and S2B). Because K33E and Y264H each caused only mild telomere shortening, the stronger phenotype of ssb1–1 (K33E-Y264H) indicates that these two mutations contribute additively to telomere shortening (Figs 1C and S2D). Unlike W523C, all integrated single-site mutants maintained stable telomeres even after extensive outgrowth. We next asked whether the telomere shortening in these ssb1 mutants reflects defective telomerase recruitment. Chromatin immunoprecipitation (ChIP) assays for Trt1 detected near-wt-level or increases in telomere binding for all mutants (Figs 1D and S2E). Thus, telomere shortening in these strains cannot be explained by reduced telomerase recruitment and instead might reflect impaired ability of telomerase to extend telomeres. Because the fission yeast Tpz1 TEL-patch mutant K75A is also defective in telomerase activation [8], we asked whether the identified Ssb1 residues act redundantly with the Tpz1 TEL-patch. When combined with tpz1-K75A, milder ssb1 mutants (L222A and Y264H) maintained short telomeres comparable to tpz1-K75A alone (S2F Fig). By contrast, stronger telomere-shortening mutants (L355P, Y474N, C482S, and K484E) showed severe telomere dysfunction in the tpz1-K75A background. Multiple double mutant clones either lost telomeres completely or displayed subtelomeric rearrangements and telomere amplification (S2G-S2H Fig). These results identify L355, Y474, C482, K484, and especially W523 as key Ssb1 residues for telomere maintenance. To place these residues in a structural context, we mapped them onto the X-ray crystal structure of Ustilago maydis RPA bound to ssDNA [38] (Figs 1E and S3A). In the DBD-C domain (Fig 1A), W523 contacts a DNA base directly, whereas Y474, C482, and K484 cluster around the ssDNA. Nearby K497, which causes mild telomere shortening, lies in the same structural region. In the DBD-B domain, L355 lies adjacent to W356, which also contacts a DNA base, suggesting that L355P may disrupt the ssDNA-binding function of the neighboring W356. Consistent with this idea, recent work in budding yeast showed that rfa1-W360A (W356 in Ssb1) causes progressive telomere loss and replicative senescence [22]. On the other hand, budding yeast rfa1-Y483L (Y474 in Ssb1) was found to maintain extremely short, yet stable, telomeres [22]. Among the DBD-A mutants, Y264 likewise contacts a DNA base. Although not yet tested in fission yeast, the DBD-C residues F527 and R570, corresponding to the budding yeast rfa1-F537A and R580E, which cause very short telomeres [22], are also positioned adjacent to ssDNA. These observations indicate that Ssb1/RPA1 residues proximal to ssDNA are among the most important determinants of RPA function at telomeres. Ssb1-W523C uncouples telomerase recruitment from telomerase activation We next asked why ssb1-W523C cells lose telomeres. In fission yeast, the Rad3ATR–Rad26ATRIP kinase complex promotes telomerase recruitment by stimulating the Ccq1–Est1 interaction [6]. Because RPA-coated ssDNA recruits ATR–ATRIP and promotes phosphorylation of downstream checkpoint and DNA repair targets [39–41], we tested whether the W523C mutation affects recruitment of RPA, Rad3–Rad26, or telomerase to telomeres. Since telomeres in W523C cells show progressive shortening, we constructed and used a series of isogenic strains spanning longer-than-wt to progressively shorter telomeres (see Materials and Methods and S5 Fig) and monitored telomere-length-dependent changes in protein association by ChIP. Both RPA (Ssb2 and Ssb3) and the ATR complex (Rad26) exhibited robust binding to telomeres in ssb1-W523C cells, and this binding increased significantly as telomeres shortened (Fig 2A-2C). Consistently, ssb1-W523C cells exhibit a higher fraction of cells with intense Ssb3-GFP foci upon telomere shortening, while the frequency of Ssb3-GFP foci formation in the isogenic strain with longer telomeres was comparable to ssb1+ cells, indicating that the W523C mutation does not likely cause a general defect in DNA replication or DNA damage responses (S4B–S4C Fig). ssb1-W523C cells exhibit a telomerase activation defect. (A-G) Binding of the indicated proteins to telomeres in isogenic ssb1-W523C (A-D), trt1-D743A (E), tpz1-K75A (F), and trt1∆ (G) strains carrying different telomere lengths, analyzed by ChIP (top or left), with corresponding telomere length analysis of the strains used for ChIP (bottom or right). Statistical significance was assessed by ANOVA with Dunnett’s comparison test (*P ≤ 0.05; **P ≤ 0.01; ****P ≤ 0.0001). See S1 Data for individual % IP values and additional statistical analysis. Trt1 recruitment also initially increased as telomeres shortened, paralleling the accumulation of RPA and Rad26ATRIP (Fig 2D). However, once telomeres became extremely short, enhanced Trt1 binding was lost. A similar pattern of initial increase, followed by reduction, of telomere binding of Trt1 was observed in the catalytically inactive trt1-D743A mutant (Fig 2E), indicating that ssb1-W523C cells are not defective in telomerase recruitment, but instead fail to engage in productive elongation of telomeres. Notably, the defect in ssb1-W523C is more severe than in tpz1-K75A cells, because K75A cells showed substantial increases in Trt1 binding as telomeres shortened, yet stably maintained telomeres and enhanced association of Trt1 with telomeres (Fig 2F). Previous work showed that Rad3ATR/Tel1ATM kinase-dependent Ccq1-T93 phosphorylation initially increases as telomeres shorten in trt1∆ cells and subsequently disappears once telomeres become very short [42]. By contrast, phosphorylation of the checkpoint kinase Chk1 is initially suppressed but becomes strongly induced in later generations of trt1∆ cells [42]. ChIP assays explain this transition: when telomeres become very short, Rad26ATRIP binding remains robust, whereas Ccq1 binding drops dramatically (Fig 2G). Thus, loss of Ccq1 accumulation and Ccq1-T93 phosphorylation likely explain why Trt1 binding is lost in ssb1-W523C and trt1-D743A cells when telomeres become critically short. Moreover, because disruption of the Tpz1–Ccq1 interaction activates checkpoint signaling by reducing Ccq1 accumulation at telomeres [43–45], loss of Ccq1 also explains why cells with very short telomeres eventually activate Chk1. Taken together, these results identify ssb1-W523C as a separation-of-function mutant that uncouples telomerase recruitment from telomerase activation. AlphaFold3 modeling predicts a functional RPA–Trt1–Tpz1 ternary complex The RPA2–TERT and Rfa2RPA2–Est3TPP1 interactions that promote telomerase activity in humans [26] and budding yeast [22] have not been examined in fission yeast. We therefore used AlphaFold3 [31] to test whether fission yeast RPA might form analogous interactions with Trt1TERT and Tpz1TPP1. When Trt1, the N-terminal OB-fold domain of Tpz1 (aa1–219), and all three RPA subunits were included in the modeling, the top-scoring AlphaFold3 models converged on a highly similar overall architecture (S6A–S6B Fig). Although full-length Ssb1RPA1 was modeled, we focused primarily on aa177–609 because the orientation of the N-terminal OB-F domain, connected by a long linker, varied substantially across models (Figs 3 and S6A-S6B). Likewise, although full-length Ssb2 was modeled, the N-terminal unstructured region (aa1–49) and the C-terminal winged-helix (WH) domain (aa182–279) were excluded from further analysis due to their variable orientations. Moreover, truncation analysis showed that the Ssb2 WH domain is dispensable for telomere maintenance in fission yeast (S7A-S7B Fig), unlike the human RPA2 WH domain, which affects telomere maintenance but not RPA’s role as telomerase processivity factor [23,26]. Similarly, Ssb3 did not directly contact either Trt1 or Tpz1 in the AlphaFold3 models, in agreement with the observation that ssb3∆ cells maintain wt telomeres (S7C Fig). AlphaFold3 model of the RPA–Trt1–Tpz1 complex. (A-C) AlphaFold3 models containing Ssb1 (aa177-609), Ssb2 (aa50-181), full-length Ssb3, Tpz1 (aa1-219), and full-length Trt1, shown in different orientations. The models include the 3’ end of telomeric ssDNA (turquoise) and a short telomerase RNA template region (pink). DBD-A, -B, and -C of Ssb1, DBD-D of Ssb2, and OB-E of Ssb3 are indicated. (A) Overall model highlighting Trt1 catalytic site aspartates D590, D742, and D743 positioned adjacent to the 3’ end of telomeric ssDNA (small inset) and the predicted Ssb1–Trt1, Ssb2–Tpz1, and Trt1–Tpz1 interaction surfaces (large inset). (B) Detailed view of the predicted interaction of Ssb1-W523 with Trt1-E116/R119 (top inset) or with telomeric ssDNA (bottom inset). (C) Detailed view of the predicted interaction of Ssb2-W112 with telomeric ssDNA (top inset) or with Trt1-E86/N90 (bottom inset). The predicted interaction between Ssb2-T93/T94 and Trt1-D157 is also shown (bottom inset). The predicted interactions of Ssb1 and Ssb2 with Trt1 are structurally incompatible with their simultaneous engagement of ssDNA in the canonical RPA–ssDNA binding configuration. The predicted fission yeast complex resembles the overall organization of the Tetrahymena telomerase complex, which includes TERT, the telomerase processivity factor complex TEB, and the TPP1-like factor p50 [28,46–48] (S6C Fig). Because the AlphaFold3 model of RPA aligned well with the U. maydis RPA–ssDNA structure [38] (S7D-S7F Fig), we overlaid ssDNA from the crystal structure onto the RPA–Trt1–Tpz1 model (Fig 3). Based on the strong structural conservation of TERT, we also overlaid the RNA template region and telomeric ssDNA from the Tetrahymena telomerase structure, which positioned the 3’ end of telomeric ssDNA adjacent to catalytic aspartate residues D590, D742, and D743 of Trt1 (Fig 3A), required for 3’ nucleotide addition [49]. The model further predicted that Tpz1 TEL-patch residues E74 and K75 interact with Trt1 K145 and E143, respectively, thereby linking the TEL-patch to the TEN-domain of Trt1 (Figs 3A and S6D). Additional nearby interactions, including K75Tpz1–E116Tpz1 and S85Trt1–E143Trt1, may stabilize this interface (S6D Fig), and Trt1-R119 may also contact Tpz1-N122 (S6E Fig). These predictions are consistent with previous observations that tpz1-K75A and tpz1-K75E cause very short telomeres, whereas tpz1-E74R causes milder but detectable telomere shortening [8,9]. In addition to the TEL-patch interface, AlphaFold3 predicted several RPA residues to interact directly with Trt1. These include Ssb1-W523, positioned near Trt1-E116 and R119 (Fig 3B), and Ssb2-W112, positioned adjacent to Trt1-E86 and N90 (Fig 3C). The predicted W112Ssb2–E86/N90Trt1 interaction is analogous to the W107RPA2–R83TERT interaction shown to be critical for human RPA-mediated stimulation of telomerase processivity [26]. Importantly, both Ssb1-W523 and Ssb2-W112 also contact ssDNA in the canonical RPA–ssDNA structure (S7D-S7E Fig). Thus, if these residues engage Trt1 as predicted, they are unlikely to simultaneously occupy the canonical RPA–ssDNA-binding configuration (Fig 3B-3C). Indeed, persistent binding of Ssb2 to ssDNA, as in the canonical RPA–ssDNA structure, would position the 3’ telomeric end away from the Trt1 reverse transcriptase (RT) domain (Fig 3B). This suggests a mechanism in which the formation of the RPA–Trt1–Tpz1 ternary complex releases the 3’ end from RPA and channels it toward the telomerase active site. The model also predicts a stabilizing interaction between Trt1-D157 and Ssb2-T93/T94, which lie close to the W112Ssb2–Trt1 interface but do not contact ssDNA (Figs 3C and S7D). Notably, this arrangement resembles the previously identified human D147TERT–T88RPA2 interaction [26]. The model also predicted that Tpz1-R81 interacts with Ssb2 E69 and/or E76 (Figs 3A and 4A). This was surprising because earlier work classified R81 as part of the Tpz1 TEL-patch, based on complete telomere loss and failure to recruit telomerase in tpz1-R81E cells [9]. However, our analysis found that tpz1-R81E cells still exhibit robust increases in Trt1 recruitment as telomeres shorten and lose Trt1 binding only when telomeres become extremely short (Fig 4B), like ssb1-W523C and trt1-D743A cells (Fig 2D-2E). Thus, our data instead suggest that Tpz1-R81 and Ssb1-W523 likely contribute to a post-recruitment step of telomerase that is essential for telomerase activation. Characterization of ssb2 mutants predicted to affect Ssb2–Tpz1 and Ssb2–Trt1 interactions. (A) AlphaFold3 model highlighting the predicted interaction of Tpz1-R81 with Ssb2-E69/E76. (B) Trt1-myc ChIP analysis of telomere binding in isogenic tpz1-R81E strains with different telomere lengths, with corresponding telomere length analysis. (C) Telomere length analysis by Southern blot of the indicated ssb2 mutant strains in combination with tpz1-R81E after the indicated numbers of restreaks following sporulation of heterozygous diploid strains. Two independent clones are shown for each genotype. (D) Telomere length analysis by Southern blot of the indicated ssb2 mutant strains after extensive restreaks to obtain terminal telomere phenotypes. (E) Telomere length analysis by Southern blot of ssb2-W112A mutant cells after indicated numbers of restreaks following sporulation of heterozygous diploid strains. (F) AlphaFold3 model highlighting the predicted interaction of Ssb2-W112 with Trt1-E86/N90 (left inset) or with telomeric ssDNA (right inset). (G) Telomere length analysis by Southern blot of the indicated ssb2 mutant strains. All strains were extensively restreaked to obtain terminal telomere phenotypes. (H, I) ChIP analysis of telomere binding by Ssb2-FLAG (H) and Trt1-myc (I) in the indicated ssb2 mutant strains, with corresponding telomere length analysis of the strains used for ChIP. For all ChIP assays, statistical significance was assessed by ANOVA with Dunnett’s comparison test (*P ≤ 0.05; ***P ≤ 0.001; ****P ≤ 0.0001). See S1 Data for individual % IP values and additional statistical analysis. Taken together, the AlphaFold3 analysis provides a mechanistic framework for a RPA–Trt1–Tpz1 ternary complex in which RPA–TERT and RPA–Tpz1 interactions collaborate with the Tpz1 TEL-patch to promote engagement of the telomeric 3’ end with the Trt1 catalytic center. Ssb2RPA2-mediated interfaces with Tpz1 and Trt1 contribute to productive telomere maintenance To test the predicted Ssb2–Tpz1 interface, we mutated Ssb2 residues E69 and E76, which are predicted to interact with Tpz1-R81. If the AlphaFold3 prediction is correct, charge-reversal mutations in Ssb2 might rescue the interaction defect caused by tpz1-R81E. Indeed, ssb2-E69R and ssb2-E69R-E76R, but not ssb2-E76R, rescued telomere loss in tpz1-R81E cells (Fig 4C). However, they did not restore wt telomere length, indicating that Tpz1-R81 remains important even when the charge interaction is partially compensated. This suppression required telomerase, because the corresponding tpz1 ssb2 double mutants failed to maintain telomeres in a trt1∆ background (S8A Fig). In a tpz1+ background, ssb2-E69R caused milder telomere shortening than ssb2-E76R, whereas ssb2-E69R-E76R produced the shortest telomeres (Fig 4D), indicating that E76 is more important than E69, although both contribute to telomere maintenance. Consistent with this interpretation, E76R and E69R-E76R, but not E69R, exhibited synergistic telomere loss when combined with tpz1-K75A (S8B Fig). We next examined the predicted Ssb2–Trt1 interface (Figs 3C and 4F). We found that ssb2-W112A causes progressive telomere shortening followed by telomere loss (Fig 4E), consistent with the importance of the equivalent residue in the human system [26]. By contrast, ssb2-T93A-T94A caused telomere shortening but still allowed stable telomere maintenance (Fig 4G). T94 is found to be more important than T93, because ssb2-T94A, but not ssb2-T93A, caused substantial telomere shortening on its own and synthetic telomere loss with tpz1-K75A (S8C Fig). To determine whether these Ssb2 mutants still bind telomeres efficiently, we performed ChIP assays. Cells carrying E69R/E76R or T93A/T94A mutations showed increased Ssb2 binding that inversely correlated with the severity of telomere shortening (Fig 4H), consistent with intact RPA binding to short telomeres. In contrast, ssb2-W112A did not show increased telomere binding to short telomeres despite robust Ssb2 protein expression (Figs 4H and S8D). Because W112 lies adjacent to ssDNA in the RPA–ssDNA complex (Figs 4F and S7D-S7E), this mutation might weaken not only telomeric binding but also RPA association with non-telomeric ssDNA, consistent with the poor growth of ssb2-W112A cells. ChIP assays for Trt1 showed that both ssb2-E69R-E76R and ssb2-T93A-T94A cells recruit moderately increased levels of telomerase to short telomeres (Fig 4I), indicating that telomere shortening in these strains reflects reduced telomerase activity per recruited complex rather than defective recruitment. Indeed, even tpz1-R81E ssb2-T93A-T94A double mutants retained Trt1 binding (S8E Fig), indicating that robust telomerase recruitment can still occur even when both Ssb2–Tpz1 and Ssb2–Trt1 interfaces are simultaneously compromised. In contrast, ssb2-W112A cells showed a severe reduction in Trt1 binding in early generations before eventual telomere loss (Fig 4I), indicating that this mutation affects telomerase recruitment, consistent with an impairment of the RPA–Rad3ATR-dependent Ccq1–Est1 pathway due to poor RPA association at telomeres. On the other hand, because mutation of the equivalent residue in humans (W107RPA2) causes the most severe defect in RPA-dependent stimulation of TERT processivity [26], ssb2-W112A may also impair telomerase activation. Taken together, these experiments provide strong support for the functional roles of the two predicted Ssb2–Tpz1 and Ssb2–Trt1 interfaces in productive telomere maintenance. Redundant RPA-telomerase-shelterin interactions ensure productive telomerase engagement To complement the Ssb2 mutational analysis, we next mutated Trt1 residues predicted to reside at the Ssb1–Trt1 and Ssb2–Trt1 interfaces. Mutations E86A, E86A-N90A, E116A, R119A, E116A-R119A, and D157A in Trt1 all caused telomere shortening, whereas N90A maintained near wt telomere length (Figs 5A and S8F). Western blot analysis confirmed that these Trt1 mutations do not impair Trt1 protein expression (S8G Fig), and all mutants stably maintained their shortened telomeres. Ssb1–Trt1, Ssb2–Trt1, Trt1–Tpz1, and Ssb2–Tpz1 interactions redundantly regulate productive telomerase engagement with telomeric 3’ ends. (A, B) ChIP analysis of the indicated trt1 mutants in tpz1+ (A) or tpz1-K75A (B) background, with corresponding telomere length analysis by Southern blot of the strains used for ChIP. Statistical significance was assessed by ANOVA with Dunnett’s comparison test (*P ≤ 0.05; **P ≤ 0.01). See S1 Data for individual % IP values and additional statistical analysis. (C, D) Telomere length analysis by Southern blot of the indicated trt1 mutants in ssb2-E69R-E76R (C) and ssb2-T93A-T94A (D) backgrounds. All strains were extensively restreaked to obtain terminal telomere phenotypes. (E) Schematic representation of fission yeast Trt1 constructs previously shown to induce chromosome circularization upon reintroduction into trt1∆ taz1∆ survivor cells [51,52]. (F-H) Analysis of telomere loss in trt1∆ taz1∆ cells after reintroduction of plasmids expressing catalytically inactive trt1-D743A or taz1+ in either ssb1+ or ssb1-W523C backgrounds (F), tpz1-K75A or tpz1-R81E backgrounds (G), or various trt1-mutant plasmids in trt1∆ taz1∆ cells (H). When combined with tpz1-K75A, however, nearly all Trt1 interface mutants, except for N90A, lost telomeres (S8H Fig), highlighting the importance of these residues for telomere maintenance. ChIP assays showed increased telomere occupancy for all tested Trt1 mutants (Fig 5A), consistent with the elevated telomerase association typically observed in short-telomere strains. Thus, these telomerase mutants reduce productive telomere extension per telomere-bound telomerase complex rather than telomerase recruitment. To test how these Trt1 residues interact functionally with the Tpz1 TEL-patch, we measured binding of the same Trt1 mutants in a tpz1-K75A background before eventual telomere loss. We found that trt1 tpz1-K75A double mutants no longer showed increased Trt1 binding despite carrying short telomeres (Fig 5B), suggesting that the Ssb1/2-Trt1 interactions and the Tpz1 TEL-patch provide partially redundant contributions that together stabilize or enhance Trt1 association with short telomeres, while they are not required for telomerase recruitment per se. We next tested genetic redundancy among the Ssb1–Trt1, Ssb2–Trt1, and Ssb2–Tpz1 interfaces. When ssb2-E69R-E76R, affecting the Ssb2–Tpz1 interface, was combined with trt1-E86A or trt1-D157A of the Ssb2–Trt1 interface or with trt1-E116A-R119A of the Ssb1–Trt1 interface, all double mutants exhibited synergistic telomere loss (Fig 5C). Likewise, combining ssb2-T93A-T94A at the Ssb2–Trt1 interface with trt1-E116A-R119A resulted in synergistic telomere loss (Fig 5D). By contrast, when ssb2-T93A-T94A was combined with trt1-E86A or trt1-D157A, which are all predicted to affect the Ssb2–Trt1 interaction, double-mutants maintained telomeres even after extensive restreaking, although E86A showed additional telomere shortening in this background (Fig 5D). These results, together with the synergistic telomere loss observed when tpz1-K75A (Trt1–Tpz1 interface) was combined with mutants affecting either the Ssb2–Tpz1 or Ssb2–Trt1 interfaces (S8B-S8C Fig), support the view that the Ssb1–Trt1, Ssb2–Trt1, Ssb2–Tpz1, and Trt1–Tpz1 interfaces make partially redundant but non-overlapping contributions that collectively promote productive telomere extension by telomerase. Notably, ssb1-W523C, ssb2-W112A, and tpz1-R81E differ from other interface mutants in that each causes complete telomere loss on its own. This suggests that those mutations may affect not only the specific interfaces predicted by the model, but also additional aspects of telomere maintenance, such as telomerase recruitment (i.e., ssb2-W112A), substrate positioning, or coordination of telomerase action with replisome dynamics at telomeres. Shelterin mutations allow telomerase-dependent maintenance of telomeres in ssb1-W523C, but not tpz1-R81E The severe telomere-loss phenotypes of ssb1-W523C and tpz1-R81E raised the question of why telomerase, even when efficiently recruited, fails to maintain telomeres in these mutants. To gain further mechanistic insight, we investigated whether shelterin-related mutations that cause elongated telomeres could suppress telomere loss in these mutant backgrounds. We found that combining ssb1-W523C with tpz1-K242R, tpz1-AWAAA, poz1∆, or rap1∆ enabled W523C cells to maintain stable telomeres in a telomerase-dependent manner (S9A-S9C Fig). However, telomeres remained very short, indicating that telomerase was still less efficient than in wt cells. SUMOylation of Tpz1-K242 promotes recruitment of Stn1–Ten1–Polα [10–12], and the SWSSS motif in Tpz1 contributes redundantly to Tpz1–Stn1 interaction while also playing an additional role in telomerase inhibition [12]. Likewise, both poz1∆ and rap1∆ substantially delay the recruitment of Stn1–Ten1–Polα to telomeres during late S/G2 [50]. Thus, the common feature of these W523C suppressors is prolonged and enhanced accumulation of ssDNA, RPA, and telomerase at telomeres, which may provide additional time for a partially impaired telomerase complex to extend telomeres. In contrast, none of these telomerase-dependent suppressors rescued tpz1-R81E (S9D-S9E Fig), indicating that increased RPA accumulation is not sufficient to bypass the activation defect in tpz1-R81E cells. We did observe that taz1∆ allows both ssb1-W523C and tpz1-R81E cells to maintain stable telomeres (S9F-S9G Fig), but suppression also occurred in a trt1∆ background, suggesting that this rescue may reflect the homologous recombination (HR)-based mechanism of telomere maintenance, analogous to trt1∆ taz1∆ cells [35,51,52]. These results distinguish two types of defects: ssb1-W523C, which can be partially overcome by prolonging the time window for telomerase action, and tpz1-R81E, which appears to be more fundamentally defective in the telomerase activation step itself. RPA–Trt1, RPA–Tpz1, and Tpz1-Trt1 interactions are required for catalytically inactive telomerase to inhibit recombination-dependent telomere maintenance The HR-dependent mechanism that maintains telomeres in trt1∆ taz1∆ cells requires Tel1ATM, Rad51, Rad52, Mre11–Rad50–Nbs1 (MRN) complex, and Rap1 [35,51,52]. Because Taz1 suppresses telomere recombination, reintroduction of a taz1+ plasmid causes telomere loss and chromosome circularization of trt1∆ taz1∆ survivors [51,52]. Previous work further showed that plasmids expressing catalytically inactive Trt1 (D743A or D590A) or a Trt1-∆T/RT truncation construct lacking the RT domain can likewise inhibit recombination and force telomere loss in trt1∆ taz1∆ cells [51,52] (Fig 5E-5F). Notably, these Trt1 mutant constructs all retain the wt TEN-domain, which is predicted to mediate Trt1 interactions with RPA and Tpz1. We therefore asked whether the predicted RPA–Trt1–Tpz1 interaction interfaces are required for catalytically inactive Trt1 to inhibit recombination. When Trt1-D743A was introduced into trt1∆ taz1∆ cells carrying additional mutations that disrupt the Ssb1–Trt1 (ssb1-W523C), Trt1–Tpz1 (tpz1-K75A), or Ssb2–Tpz1 (tpz1-R81E) interfaces, the plasmid failed to cause telomere loss (Fig 5F-5G). Importantly, these same mutations did not prevent telomere loss induced by reintroduction of Taz1, indicating that the defect is specific for telomerase-dependent inhibition of telomere recombination. Similarly, introducing additional Trt1 mutations predicted to disrupt the Ssb1–Trt1 (E116A or R119A) or Ssb2–Trt1 (E86A or D157A) interfaces rendered the Trt1-D743A plasmid ineffective at forcing telomere loss in trt1∆ taz1∆ cells (Fig 5H). These results provide an independent functional test of the AlphaFold3 model and show that RPA–Trt1, RPA–Tpz1, and Trt1–Tpz1 interactions are required for catalytically inactive telomerase to inhibit recombination-dependent telomere maintenance. Thus, the same interaction network that promotes productive telomere extension in telomerase-positive cells also enables catalytically dead telomerase to block recombination-based telomere maintenance. RPA–Trt1–Tpz1 regulation of telomerase is likely conserved in budding yeast and humans Because Ssb1-W523 is highly conserved across eukaryotes, we next asked whether the equivalent residue in budding yeast, Rfa1-W533, also contributes to telomere maintenance. Freshly generated rfa1-W533C cells showed progressive loss of cell viability, followed by the emergence of survivor cells that maintained short telomeres, in some cases with evidence of subtelomeric rearrangements (Fig 6A-6B). Combining rfa1-W533C with rad52∆ caused much earlier and more severe loss of viability (Fig 6C), indicating that Rad52-dependent telomere recombination [53] improves survival of rfa1-W533C cells. ChIP assays further showed that the budding yeast telomerase regulatory subunit Est1 is recruited to telomeres at levels similar to those in wt in rfa1-W533C cells (Fig 6D). Thus, as in fission yeast, the primary defect is not telomerase recruitment but rather productive telomerase action after recruitment. Since early generation rfa1-W533C cells grew comparably to wt cells (Fig 6C) and did not show severe sensitivity to MMS, HU, or CPT (S10 Fig), we believe that this mutation does not severely affect RPA’s general replisome function during telomere replication or global DNA damage responses. The Rfa1/RPA1 residue equivalent to Ssb1-W523 contributes to telomerase function in budding yeast and humans. (A) Growth curve analysis of budding yeast rfa1-W533C strains, carrying the equivalent mutation to fission yeast ssb1-W523C. (B) Telomere length analysis by Southern blot of two independent rfa1-W533C clones after successive restreaks. (C) Cell viability assay of budding yeast rfa1-W533C rad52∆ cells. YPDA plates from the indicated restreaks were photographed after incubation at 30°C for 2 days. (D) ChIP analysis of telomere binding by the budding yeast telomerase subunit Est1-myc in RFA1 and rfa1-W553C strains. Statistical significance was assessed by ANOVA with Dunnett’s comparison test (ns stands for not significant; ***P ≤ 0.001). See S1 Data for individual % IP values and statistical analysis. (E-G) Direct telomerase assay showing effects of wt and mutant human RPA complexes on telomerase activity and processivity. The in vitro telomerase assay PAGE (E) is quantified to monitor changes in repeat addition processivity (F) and total activity (G). Previously established strongest RPA processivity mutant RPA2-W107A, as well as RPA1-E240K, which causes telomere shortening but does not affect processivity, were included as controls. For (F-G), Statistical significance was assessed by ANOVA with Dunnett’s comparison test (ns stands for not significant; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001). See S1 Data for individual values and additional statistical analysis. (H) AlphaFold3 model for budding yeast RPA–Est2–Est3 complex interactions. Rfa1 W533 and Est3 L171 interact with adjacent sites on Est2 (top inset), and Rfa2 E65 interacts with Est3 K71 (bottom inset). (I) Comparison of Ssb2/Rfa2 to Tpz1/Est3 interactions between fission and budding yeast. Showing K71Est3–E65Rfa2 and S113Est3–D56Rfa2 interactions in budding yeast (left panel), and R81Tpz1–E69Ssb2 and S79Tpz1–D67Ssb2 interactions in fission yeast (right panel). (J) Detailed structures of Rfa2-Est2-Est3 interface in budding yeast, fission yeast (Ssb2–Trt1–Tpz1), and human (RPA2–TERT–TPP1). Corresponding RPA2–TERT interactions are indicated. (K) AlphaFold3 model of human RPA–TERT–TPP1complex. W528RPA1–G106/A107TERT (top panel) and D61RPA2–R220TPP1 (bottom panel) interactions are shown. Human RPA functions as a telomerase processivity factor [26]. We therefore also tested whether the human equivalent residue, RPA1-W528, contributes to this RPA function. Direct telomerase assays revealed that purified RPA complexes containing RPA1-W528A or RPA1-W528C showed a substantially reduced stimulation of telomerase processivity, with the W528A mutation having a stronger effect than W528C and an effect comparable to that of RPA2-W107A [26] (Fig 6E-6G). Together, these results indicate that RPA1-W528 contributes to RPA-mediated stimulation of telomerase processivity. However, future studies, such as the establishment of cell lines expressing RPA1-W528 mutant alleles, will be required to evaluate the impact of RPA1-W528 mutations on telomere maintenance in human cells. Because RPA’s role in modulating telomerase activity after recruitment appears to be broadly conserved, we expanded our AlphaFold3 structural modeling analysis for RPA–Trt1–Tpz1-like complexes to budding yeast and humans. AlphaFold3 models of the budding yeast RPA-Est2TERT–Est3TPP1 complex (Figs 6H and S11A-S11D) suggested that Rfa1-W533 contacts Est2 at an interface analogous to the Ssb1–Trt1 interface identified in fission yeast (Fig 3B). Notably, the predicted RPA-Est2-Est3 structure was consistent with a recently published cryo-EM structure of the Est2-Est3 interface, and the predicted RPA-interacting surfaces are available to interact with RPA in the context of the holoenzyme complex, consisting of TLC1 RNA, Est1–3, and Pop1, 6, and 7 subunits [54] (S11E Fig). Interestingly, the budding yeast Est3-L171 residue, previously classified as a TELR residue [55], was predicted to contact either the Est2 region adjacent to Rfa1-W533 or the Rfa1-W533 itself, suggesting that Est3-L171 may collaborate with Rfa1-W533 in stabilizing the RPA-Est2-Est3 complex (Figs 6H and S11F). The AlphaFold3 model also predicted that Est3-K71, another residue classified as TELR [55], interacts with Rfa2-E65 (Fig 6H), consistent with recent work showing reciprocal rescue between est3-K71E and rfa2-E65K mutations [22]. Although the residues linking the RPA2 subunit to the TPP1-like protein have diverged, this interaction appears functionally analogous to the R81Tpz1-E69Ssb2 interaction in fission yeast (Figs 6I and S3D). The two Ssb2–Trt1 interactions identified in fission yeast, W112Ssb2–E86Trt1 and T93/94Ssb2–D157Trt1, appear to be well conserved in humans [26] (Fig 6J). In budding yeast, Rfa2-W101 is predicted to interact with Est2-D58 (Fig 6J), although this contact is shifted relative to the equivalent interface in fission yeast and humans. In contrast, Rfa2-T82, the equivalent of Ssb2-T93/T94 and human RPA2-T88, is not predicted to contact Est2 (Fig 6J). Although the budding yeast rfa2-W101K mutant exhibits substantial telomere shortening [22], the phenotype is much milder than the complete telomere loss caused by ssb2-W112A in fission yeast or the loss of telomerase stimulation activity caused by human RPA2-W107A mutant [26]. Likewise, mutations at Rfa2-W101 do not cause strong growth defects in budding yeast [56,57], unlike ssb2-W112A in fission yeast, suggesting that this residue is less critical for overall RPA function in budding yeast. Finally, AlphaFold3 modeling of the human RPA–TERT–TPP1 complex [26] (Figs 6K and S12) predicts that RPA1-W528 contacts G106 and A107 in TERT. Notably, the disease-associated TERT-G106W mutation causes a severe reduction in telomerase activity in patients with cryptic Dyskeratosis Congenita (cDKC) [58], and nearby TERT mutations, G110A and V119M, likewise cause severe telomere shortening [59]. Thus, these observations support the idea that the RPA1–TERT interface is also functionally important in humans. Collectively, the experimental data and structural modeling presented in this study support a model in which coordinated RPA–TERT and RPA–Tpz1/TPP1 interactions enable telomerase to productively extend telomeric ssDNA in a wide variety of organisms. Discussion The RPA–Trt1–Tpz1 module links telomerase recruitment to productive telomere extension Earlier work in budding yeast and fission yeast suggested that the RPA complex contributes to telomere maintenance and may collaborate with telomerase and telomere-associated proteins [21,33]. However, a mechanistic explanation for these observations remained unclear. Evidence that an RPA-like complex can function as a core telomerase cofactor first emerged from studies of Tetrahymena thermophila, where cryo-EM structures revealed that the RPA-like TEB complex forms an integral component of the telomerase holoenzyme and promotes repeat-addition processivity by positioning telomeric ssDNA for nucleotide addition [28,46,48]. Whether canonical RPA performs an analogous function in other eukaryotes remained uncertain until recent studies demonstrated that budding yeast RPA2 interacts with the TPP1 ortholog Est3 to regulate telomerase activity [22], and that human RPA stimulates telomerase processivity through a defined RPA2-TERT interaction [26]. In this work, we identify a ternary RPA–Trt1–Tpz1 complex in fission yeast that couples telomerase recruitment to productive telomere extension. Genetic dissection of multiple interaction interfaces, combined with AlphaFold3-guided structural modeling, supports a model in which RPA directly contributes to telomerase activation at chromosome ends. Most notably, the ssb1-W523C mutation uncouples telomerase recruitment from productive telomere extension, as ssb1-W523C cells accumulate robust levels of RPA, Rad26ATRIP, and Trt1TERT at progressively shortening telomeres, yet ultimately lose all telomeric repeats and circularize chromosomes (Fig 2A-2D). Thus, in this mutant background, telomerase is recruited but unable to extend telomeric ends. This separation-of-function phenotype demonstrates that RPA is not merely a passive ssDNA-binding factor but plays an active role in telomerase activation. Our AlphaFold3-guided genetic analysis supports the existence of four functionally important interaction surfaces, Ssb1–Trt1, Ssb2–Trt1, Ssb2–Tpz1, and the TEL-patch mediated Trt1–Tpz1 interaction, that together define a regulatory network linking RPA to telomerase activation. These interactions likely enable assembly of an RPA–Trt1–Tpz1 complex that promotes productive engagement of the telomeric 3’ end with the telomerase catalytic center (Figs 3 and 7A). Consistent with this model, the strongest telomere-maintenance defects observed in this study map to residues within the DBD-C domain of Ssb1 and the DBD-D domain of Ssb2, domains positioned to coordinate ssDNA binding with interaction surfaces involving Trt1 and Tpz1. In particular, ssb1-W523C, ssb2-W112A, and tpz1-R81E each disrupt residues predicted to participate in these interfaces and each cause complete telomere loss in fission yeast, but the underlying defects are not identical. Working model for fission yeast telomere regulation by RPA and shelterin. (A) Model illustrating the change in interactions when RPA is bound to telomeric ssDNA (left) versus when RPA engages Trt1 and Tpz1 (right). Residues identified in this study as contributing to telomere maintenance and protein-protein interactions are indicated. (B) A working model for how RPA-coated telomeric ssDNA 3’ overhangs promote telomerase recruitment and activation. RPA bound to ssDNA recruits Rad3ATR–Rad26ATRIP, facilitating Ccq1-T93 phosphorylation and subsequent telomerase recruitment. Direct protein-protein interactions among RPA, Trt1, and Tpz1 promote the release of the 3’ ssDNA end into the telomerase catalytic site, enabling telomere extension. Recruitment of Pot1 and Stn1–Ten1–Polα promotes C-strand synthesis and completion of the replication cycle. ChIP assay showed that ssb2-W112A exhibits reduced accumulation of Ssb2 at short telomeres and severely diminished Trt1 association in early-generation cells (Fig 4H-4I), indicating that this mutation compromises telomerase recruitment. Thus, ssb2-W112A is not a clean separation-of-function activation mutant, but rather a particularly severe allele that disrupts both RPA association with telomeres and the predicted Ssb2–Trt1 interface. In contrast, ssb1-W523C and tpz1-R81E are better interpreted as post-recruitment mutants, because both retain increased Trt1 binding to shortening telomeres before eventual telomere loss (Figs 2D and 4B), indicating that telomerase recruitment occurs, but productive telomere extension is impaired. The distinct suppression profiles of ssb1-W523C and tpz1-R81E indicate that the Ssb1–Trt1 and Ssb2–Tpz1 interfaces make qualitatively different contributions within the ternary complex. Suppression of ssb1-W523C by mutations that prolong the persistence of RPA-coated ssDNA suggests that the Ssb1–Trt1 interaction primarily enhances the efficiency of telomerase within a limited temporal window, allowing telomerase to overcome inhibitory effects imposed by shelterin and Stn1–Ten1. In contrast, the inability of these suppressors to rescue tpz1-R81E, except through restoration of the predicted electrostatic interaction with Ssb2, suggests that the Tpz1-Ssb2 interface plays a more fundamental role in enabling productive engagement of telomeric ssDNA by telomerase. These interactions function together with the previously described TEL-patch-mediated Trt1–Tpz1 interaction [8,9] to promote productive extension of telomeric ssDNA with telomerase following recruitment through the Rad3ATR/Tel1ATM–Ccq1–Est1 pathway [6]. Comparative analysis of AlphaFold3-predicted structures further suggests that analogous interaction networks operate in budding yeast and humans (Figs 6 and S13). Taken together, these observations support a model in which RPA acts as a conserved architectural component of telomerase regulatory assemblies, coordinating interactions between TERT and TPP1-like factors to enable efficient telomere elongation. A model for RPA- and Tpz1-mediated telomerase regulation during DNA replication Integrating our findings with prior work, we propose a working model describing how RPA accumulation at telomeres is regulated during DNA replication and how elevated RPA levels facilitate telomerase-mediated telomere extension (Fig 7B). In fission yeast, telomeric RPA-coated ssDNA arises from multiple replication-coupled processes during S-phase. At lagging-strand replicated telomeres, ssDNA accumulates because lagging-strand synthesis is delayed relative to the arrival of the replicative CMG helicase and the leading-strand DNA polymerase Polε [13,50]. At leading-strand replicated telomeres, the MRN complex, together with the RecQ helicase Rqh1, Exo1, and Dna2, generates an RPA-coated 3’ ssDNA overhang [60–62]. Replication fork stalling, reversal, or collapse near chromosome ends may further contribute to the accumulation of RPA-coated ssDNA at telomeres [63]. Accumulation of RPA-coated ssDNA increases dramatically as telomeres shorten (Fig 2), promoting Rad3ATR–Rad26ATRIP association and phosphorylation of Ccq1-T93, which in turn stimulates the Ccq1-Est1 interaction and preferential recruitment of telomerase to shorter telomeres [6,42,50]. Several mechanisms likely contribute to this length-dependent feedback. Shorter telomeres contain fewer Taz1 binding sites, leading to altered replication timing and increased exposure of ssDNA [50,63,64]. In addition, shorter telomeres may also undergo increased MRN-dependent resection due to reduced Ccq1 binding (Fig 2G) [65]. However, this positive feedback has a lower limit: when telomeres become critically short, shelterin can no longer accumulate efficiently, leading to loss of both Ccq1 and telomerase binding despite persistent RPA and ATR association (Figs 2D, 2E, 2G and 4B). RPA likely promotes telomere extension through several distinct mechanisms. First, it maintains the telomeric 3’ overhang in an accessible single-stranded conformation by resolving secondary structures, such as G-quadruplexes [34,66,67]. Second, it facilitates telomerase recruitment by promoting assembly of Rad3ATR–Rad26ATRIP and the subsequent Ccq1–Est1 interaction [42,68]. Third, and most central to this study, formation of the RPA–Trt1–Tpz1 complex likely promotes transfer of the telomeric 3’ end from the canonical RPA-bound state to the telomerase catalytic site (Figs 3 and 7). In this model, coordinated interactions among RPA, Tpz1, and Trt1 position the substrate for productive extension while limiting inappropriate access of recombination factors such as Rad52. As telomerase extends the 3’ end, the RPA–Trt1–Tpz1 complex may translocate along telomeric DNA, leaving newly synthesized ssDNA behind. The fate of this ssDNA likely determines whether telomere extension continues or terminates. Binding by additional RPA and ATR complexes may reinforce signaling to Ccq1 and telomerase retention, whereas binding by Pot1 promotes transition to a protected, telomerase-inaccessible state. This transition is coordinated with C-strand synthesis by the Stn1–Ten1–Polα complex. As C-strand synthesis proceeds, RPA is displaced, the overhang is converted to dsDNA, and Taz1 binding is restored, promoting Rap1-Poz1 assembly and Tpz1 SUMOylation, which further enhances Stn1–Ten1–Polα recruitment [12,18]. Ultimately, the remaining G-rich overhang is bound by Pot1, restoring a fully protected telomere state (Fig 7B). Replication-coupled accumulation of telomeric RPA-coated ssDNA is conserved across eukaryotes, and S-phase-specific accumulation of telomeric overhangs has been well documented [69–71]. In these systems, lagging-strand telomeres accumulate ssDNA due to delayed fill-in synthesis, whereas leading-strand telomeres undergo MRN-mediated resection [71–74]. This conservation suggests that the RPA-dependent telomerase activation mechanism described here may operate broadly across eukaryotes. Proteomic analyses of replicating human telomeres show enrichment of RPA, TPP1, and hTERT, but reduced levels of POT1 [75]. In addition, POT1 appears to be dispensable for telomerase-mediated telomere extension in mouse embryonic stem cells [76]. Together with evidence that POT1 primarily restrains telomerase by promoting CST-mediated C-strand synthesis [71], these findings support a model in which RPA–TERT–TPP1 assemblies play a central role during active telomere extension, whereas POT1 primarily terminates extension and restores the protected state. Evolutionary conservation of the RPA-TERT-TPP1 complex All four interaction interfaces identified in the fission yeast RPA–Trt1–Tpz1 complex have predicted counterparts in budding yeast and humans (S13 Fig). Although direct structural validation remains limited, AlphaFold3 modeling provides a framework for rationalizing and re-evaluating decades of prior genetic and biochemical observations across these systems. Despite extensive sequence divergence among Tpz1, Est3, and TPP1, structural modeling suggests that these proteins share a conserved fold and overall architecture. A key feature emerging from these structure model-based comparisons is that, while the global organization of the ternary complex appears conserved, specific residue-level interactions have been extensively rewired. Equivalent residues are often predicted to engage different partners, or distinct regions of the same partner, thereby generating organism-specific interaction modes within a conserved functional module (S3 and S13C Fig). Several selected examples illustrate this principle. The TEL-patch residues E74 and K75 of Tpz1 occupy positions structurally equivalent to E168 and E169 on human TPP1, yet are predicted to contact different regions of their respective telomerase catalytic subunits, namely K145 and E143 on fission yeast Trt1 (S3C-S3D and S6D Fig) versus R774 and Y772 on human TERT (S13B Fig) [77,78]. The budding yeast Est3 TEL-patch residue E114 interacts with Est2-K62 [54] (S13A Fig), whereas the structurally analogous Tpz1-R81 residue in fission yeast does not contact Trt1 but instead reaches across to Ssb2-E69 (Figs 4A and S3D). Against this backdrop of interface reshuffling, one class of contacts appears to have remained particularly stable: residues equivalent to Ssb1-W523 and Ssb2-W112 are consistently predicted to participate in RPA–TERT interactions across all three organisms. Importantly, these predicted contacts are structurally incompatible with the simultaneous binding of these residues to ssDNA, and studies supported their positive contribution to telomere maintenance in budding yeast and humans (Fig 6) [22,26]. These tryptophan residues of RPA, therefore, appear to define the most deeply conserved elements of the RPA–TERT interfaces. The AlphaFold3 model of the budding yeast RPA-Est2-Est3 complex also offers a useful framework for interpreting earlier Rfa2 and Est3 mutagenesis data. For example, rfa2-D56K causes severe telomere shortening and replicative senescence [22], and AlphaFold3 predicts that Rfa2-D56 interacts with Est3-S113, a contact that appears to be conserved in fission yeast, where the equivalent Ssb2-D67 contacts Tpz1-S79 (Fig 6I). Interestingly, despite being predicted to interact with Rfa2-D56, est3-S113R shows no telomere defects [55], likely because this mutation retains favorable ionic interactions with Rfa2-D56. It will therefore be interesting to test whether est3-S113D causes a stronger telomere phenotype and whether it can suppress the senescence phenotype of rfa2-D56K. Analogous experiments could test the functional relevance of the predicted equivalent interaction in the fission yeast ternary complex. Remarkably, AlphaFold3 predicts that human RPA2-D61 (equivalent to Ssb2-D67 and Rfa2-D56) also contacts TPP1-R220 within the RPA–TERT–TPP1 complex (Figs 6K and S12D), suggesting unusually strong evolutionary conservation of this RPA2-centered interaction node (S13C Fig). TPP1-R220 lies within the TELR region (R218-V221), originally identified by structural comparison with budding yeast Est3 and thought to be functionally analogous to the Est3-L171 region [79]. Mutations in the TPP1 TELR region impair TPP1-mediated telomerase stimulation and disrupt telomere maintenance in human cells without affecting telomerase recruitment [79], supporting the relevance of the predicted RPA2–TPP1 interface. At the same time, Est3 L171 is predicted to support the W533Rfa1–Est2 interface rather than contacting Rfa2 (Figs 6H and S9E). Thus, conserved TELR sites may contribute to telomere maintenance through distinct mechanistic routes across organisms. Further expanding on prior experimental and modeling work on the human RPA–TERT–TPP1 complex [26], AlphaFold3 also suggested that TERT-R132 and TERT-E113 may interact, potentially stabilizing the TERT region predicted to interact with RPA1-W528 (S12E Fig). TERT mutations near the predicted RPA1–TERT interface impair telomerase function in human cells [58,59]. In addition, the disease-associated TERT-R132D mutation disrupts telomerase recruitment [80] and likely telomerase activation as well, because forced targeting of TERT to telomeres does not rescue its telomere maintenance defect [81]. Interestingly, whereas cryo-EM structures of the TERT–TPP1 complex place TPP1-E215 near both TERT-K78 and R132 [77], AlphaFold3 ternary complex models predict an interaction with K78 only, potentially freeing TERT-R132 to engage TERT-E113. The region of TERT predicted to contact RPA1-W528 is currently unresolved in available TERT–TPP1 cryo-EM structures [77,78], raising the possibility that including RPA in future structural analyses might stabilize this region and enable direct visualization of the proposed RPA1–TERT interaction interface. Limitations of the study The consistency of our findings in fission yeast with prior studies in budding yeast and humans suggests that RPA plays a conserved role in telomerase regulation across eukaryotes. However, several limitations should be noted. Although data from current and previous studies support the proposed interaction network, high-resolution structural determinations of RPA–TERT–TPP1/Tpz1/Est3 complexes remain lacking. In addition, key mechanistic steps, such as transfer of the telomeric 3’ end from RPA to the telomerase catalytic center, are inferred rather than directly observed. Future structural and biochemical studies will therefore be required to test the validity of these predicted assemblies. Nevertheless, the convergence of genetic, biochemical, and comparative structural modeling evidence supports a model in which canonical RPA functions not only as an ssDNA-binding factor and checkpoint platform, but also as a conserved architectural component of telomerase-regulatory complexes that couple telomerase recruitment to productive chromosome-end extension while limiting recombination-based telomere maintenance. Materials and methods Yeast strains, plasmids, and primers Yeast strains used in this study were constructed using standard methods [82–85]. S. pombe cells were cultured in YES (Yeast Extract with Supplements) medium at 32°C. For most fission yeast strains, mutations or epitope tags in RPA or Trt1 were introduced by transforming a haploid strain. For ssb2-W112A strains, the mutation (with or without an epitope tag) was introduced into diploid strains; haploid progenies were obtained by sporulation in supplemented SPA medium (SPAS) followed by tetrad dissection using a Zeiss dissection microscope. To combine mutations or epitope-tagged alleles, genetic crosses between opposite mating-type strains were performed in SPAS medium, and haploid progenies with desired genotypes were identified. Newly generated strains were repeatedly streaked on YES agar plates to obtain terminal telomere phenotypes. S. cerevisiae strains were grown at 30°C in YPDA (Yeast Peptone Dextrose Adenine) medium. The rfa1-W533C mutation was introduced into haploid or diploid budding yeast strains by transformation. Double mutants (rfa1-W533C rad52∆ or rfa1-W533C Est1-myc) were generated by transforming a diploid rfa1-W533C/RFA1 strain with the corresponding constructs, followed by sporulation and selection of haploid progenies with desired genotypes. Point mutations and truncations were generated with Q5 PCR (NEB, M0491L), Gibson Assembly (NEB, E5510S), or site-directed mutagenesis kits Q5 (NEB, E0554S) or QuikChange Lightning (Agilent, 210519) on plasmids carrying the gene of interest. All constructs were verified by whole-plasmid sequencing (Plasmidsaurus, Louisville, KY). pRIT2-ssb1-mutant plasmids were generated and sequence verified by Genscript (Piscataway, NJ). To integrate various mutant alleles, mutant genes were either excised from plasmids or amplified by PCR and transformed into fission yeast or budding yeast cells. Correct genomic integration was verified by PCR and DNA sequencing. Fission yeast and budding yeast strain genotypes are listed in S1 and S2 Table, respectively. Plasmids used in this study are listed in S3 Table. DNA primers used in this study are listed in S4 Table. The sources of previously published mutants or epitope-tagged constructs used in this study and additional details on the construction of various newly generated alleles from this study are listed in S5 Table. Construction of elongated telomere strains Isogenic fission yeast strains with progressively shortening telomere lengths were generated by crossing rap1∆ with poz1∆ strains carrying epitope-tagged and/or mutant alleles, followed by dissection and selection of rap1+ poz1+ progenies (S5A Fig). Because rap1∆ and poz1∆ strains carry highly elongated telomeres [5,86], the resulting strains initially carry elongated telomeres. Strains were then restreaked successively, and progressive telomere shortening was monitored by telomere-length Southern blot analysis (See S5B Fig for an example of trt1-D473A-myc restreaks.) For each restreak, cells were processed to make a glycerol stock at -80oC to allow recovery of these strains with defined telomere length for later experimental use. To allow telomere elongation in rap1∆ or poz1∆ strains with trt1-D743A or trt1∆, a plasmid that expresses wt Trt1 (pREP-trt1+) was utilized (S5B-S5C Fig), while a plasmid that expresses wt Tpz1 (pREP-tpz1+) was utilized for poz1∆ strains carrying tpz1-R81E or tpz1-K75A (S5D Fig). For rap1∆ or poz1∆ strains carrying ssb1-W523C, a plasmid that expresses wt Ssb1 (pIRT2-ssb1+) was utilized to elongate telomeres (S5E Fig). Growth curve analysis Budding yeast cells were grown in YPDA at 30°C, diluted to 5x105 cells/mL in fresh medium, and cell density was measured every 24 hours over multiple days, as described previously [87]. Chromatin immunoprecipitation (ChIP) ChIP assays were performed as described previously [88]. Exponentially growing cells were crosslinked with 1% formaldehyde by addition of 1/10 volume of fixation solution (11% formaldehyde, 100 mM NaCl, 1mM EDTA pH 8.0, 0.5 mM EGTA pH 8.0, 50 mM Tris-HCl pH 8.0) for 20 min at room temperature, incubated for an additional 5 min after addition of Glycine at a final concentration of 125 mM. Cells were washed 3× with TBS (20 mM Tris-HCl, pH 7.6, 150 mM NaCl), pelleted, and frozen in liquid nitrogen. Cells were lysed in lysis buffer (50 mM Hepes-KOH pH 7.5, 140 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, Roche complete protease inhibitor cocktail) with glass beads using FastPrep-24 5G (MP Biomedicals), followed by sonication for 3x 30sec (Bioruptor Pico, Diagenode). Cleared lysates were incubated with either monoclonal anti-myc (9B11, Cell Signaling, 58730), anti-FLAG (M2 F1804, Sigma), or anti-GFP (Sigma, 11814460001) antibodies, followed by capture with Dynabeads Protein G (ThermoFisher, 10009D). ChIP DNA samples were analyzed by qPCR (BioRad CFX Duet) with PerfeCTa SYBR Green SuperMix (Quantabio, 95054–500), amplified with either fission yeast primers 637 and 638, or budding yeast primers 2371 and 2372 (S4 Table). Values were normalized to input DNA samples and expressed as %IP. Error bars represent SEM. Southern blot analysis Genomic DNA was prepared by resuspending cell pellets in equal volumes of DNA buffer (100 mM Tris pH 8.0, 1 mM EDTA pH 8.0, 100 mM NaCl, 1% SDS) and Phenol:Chloroform:Isoamyl alcohol (25:24:1), and lysing cells with glass beads using FastPrep-24 5G (MP Biomedicals). Genomic DNA (1 µg) was digested overnight with EcoRI (fission yeast) or XhoI (budding yeast), separated on 1% agarose gel, and transferred to Nytran SPC membranes (Cytiva). Fission yeast telomeres were detected using a 32P-labeled telomeric repeat probe generated by random priming of a ApaI-SacI telomere repeat DNA fragment, derived from pTELO plasmid (S3 Table). Budding yeast telomeres were detected using 32P-labeled Y’ probe generated by random priming of a PCR product amplified from budding yeast genomic DNA with primers 2220 and 2221 (S4 Table). Blots were imaged with Amersham Typhoon Phosphorimager (Cytiva). Western blot analysis Western blot analysis was performed using monoclonal anti-myc (9B11, Cell Signaling 58730), anti-FLAG (M2 F1804, Sigma), or anti-Ssb1 [30], and monoclonal anti-α-tubulin (clone B-5-1-2 T5168, Sigma) as primary antibodies. As secondary antibodies, either HRP-conjugated (goat) anti-mouse (ThermoFisher, 31430) or IRDye 800CW Goat anti-Mouse IgG (Licor, 926–32210) were used. Blots were imaged with either an Azure 400 imager for HRP detection or an LI-COR Odyssey CLx imager for fluorescent detection. Fluorescence microscopy For live-cell microscopy, cells expressing Ssb3-GFP were cultured to <0.8 OD600 in minimal media (PMG +HUAL) at 25°C in three independent experiments. Cells were then concentrated and spotted onto clear glass slides. 15-20 Z-stacks/frame (Z-step size 0.2-0.27µm) were acquired using a Yokogawa Spinning Disk confocal Leica DM8i inverted microscope with Leica CS apochromatic 100 × oil objective 1.43 NA. Prime 95B Back-illuminated sCMOS camera and Leica LAS-X software version 3.7.x were used. Maximum intensity Z-stack projections were analyzed in ImageJ and the percentages of nuclei with distinct GFP-foci were quantified for >200 individual cells on average per experiment. AlphaFold3 modeling AlphaFold3 models were generated using a web server (https://alphafoldserver.com) for the indicated proteins and analyzed with UCSF ChimeraX [89]. For S. pombe complex modeling, full-length Trt1, full-length Ssb1, Ssb2, and Ssb3, and Tpz1 corresponding to amino acids 1–219 were used. For S. cerevisiae complex modeling, all proteins used were full-length. For human complex modeling, full-length TERT, TPP1 corresponding to amino acids 87–266 (or 1–180 with a more recently revised TPP1 amino acid residue number) [90], full-length RPA1 and RPA3, and RPA2 corresponding to amino acids 1–175. The resulting representative AlphaFold3 server results are shown in S14 Fig to help evaluate the confidence of these models based on pIDDT values. For PDB accession numbers for previously published structures used in comparative analyses to AlphaFold3 models are: 4GNX (U. maydis RPA-ssDNA) [38], 7UY6 (Tetrahymena telomerase complex) [47], 6I52 (S. cerevisiae RPA-ssDNA) [91], 9SWN (S. cerevisiae telomerase complex) [54], and 7QXA (human telomerase-TPP1 complex) [77]. Expression and purification of human telomerase HEK293T cells (ATCC) were co-transfected with a modified pVan107-hTERT plasmid [92], in which TERT carried an N-terminal 3xFLAG-Twin-Strep tag, and pCDNA-U3-TR-HDV (a gift from Dr. Kelly Nguyen) at a 1:3 mass ratio using JetPrime reagent (Polyplus, France). Cells were harvested 48 hours after transfection and lysed in CHAPS lysis buffer (10 mM HEPES, pH 7.5, 1 mM MgCl2, 1 mM EGTA, 0.5% CHAPS, 10% glycerol, 5 mM TCEP, 1 mM PMSF). Lysates were clarified by centrifugation at 17,000 × g for 20 min, and the supernatant was incubated with anti-DYKDDDDK G1 affinity resin (GenScript, USA) for 2 hours at 4°C with rotation. Beads were washed with 15 column volumes of telomerase buffer (50 mM Tris-HCl, pH 8.0, 50 mM KCl, 1 mM MgCl2, 1 mM TCEP, 30% glycerol), and bound material was eluted with 2 column volumes of the same buffer supplemented with 0.5 mg/mL 3xFLAG peptide (APExBIO, USA). Eluted telomerase was concentrated using Amicon Ultra 30 kDa MWCO centrifugal filters (Millipore), snap-frozen in liquid nitrogen in small aliquots, and stored at -80°C. TERT in purified telomerase was detected and quantified by Western blot. Samples were resolved by SDS-PAGE alongside a 3xFLAG-tagged protein standard, transferred to nitrocellulose using a semi-dry transfer module, and blocked with StartingBlock Blocking Buffer (Thermo Fisher Scientific, USA) for 1 hour at room temperature. Membranes were incubated overnight at 4°C with monoclonal anti-FLAG M2-HRP antibody (Sigma-Aldrich, A8592) at the manufacturer-recommended concentration, washed 3× with 1 × PBST containing 0.5% Tween-20, and developed using SuperSignal West Pico PLUS chemiluminescent substrate (Thermo Fisher Scientific, USA). Human TR (hTR) in purified telomerase was detected and quantified by dot blot. Telomerase aliquots were incubated with Proteinase K and RNaseOUT (Invitrogen, USA) for 1 h at 37°C, mixed with an equal volume of formamide loading dye, heated to 95°C for 10 min, and spotted onto Hybond N+ membrane (Cytiva, USA) together with in vitro-transcribed hTR standards. Membranes were UV-crosslinked, pre-hybridized for 1 h at 42°C in ULTRAhyb Ultrasensitive Hybridization Buffer (Invitrogen, USA), and hybridized overnight at 42°C with 32P-labeled hTR DNA probes as described [26]. Membranes were washed twice each for 15 min at 42°C with Buffer W1 (2 × SSC, 0.1% SDS) and Buffer W2 (0.1 × SSC, 0.1% SDS), exposed to a phosphor screen, and imaged using a Typhoon RGB imager (Cytiva, USA). hTR quantification was used to determine the final concentration of purified telomerase. Expression and purification of human RPA Human RPA and its single amino acid mutants (W107A, W528A, W528C, E240K) were purified using a previously described protocol [93,94]. In summary, the plasmid p11d-tRPA (Catalog #102613, Addgene, USA) and its respective mutant plasmids were transformed into E. coli BL21(DE3) cells (New England Biolabs, USA). A single colony was picked and grown overnight in 4 L of LB medium at 37°C without shaking. They were grown the next day and induced at O.D. (600) of 0.6 by adding 0.3 mM IPTG. The cells were grown overnight at 16°C and collected the next day. The cells were resuspended in Buffer A (25 mM HEPES, 1 M NaCl, 10% Glycerol, 1 mM EDTA, 1 mM DTT, 0.5 mg/ml lysozyme, 1X Protease Inhibitor cocktail (Roche) and sonicated for lysis. The lysate was centrifuged at 35,000 x g for 45 min. The supernatant was buffer exchanged into a buffer containing 500 mM NaCl and incubated with 4 ml of HiTrap Blue beads for 1 hour at 4°C with constant rotation. It was then transferred to a gravity column and sequentially washed with 10 CV of Buffer A containing 500 mM NaCl, followed by 5 CV of Buffer A containing 800 mM NaCl. The RPA was eluted with 8 CV of Buffer A containing 2.5 M NaCl + 30% Ethylene Glycol. The eluate was diluted into a buffer containing 500 mM NaCl and incubated with 1 ml of hydrated ssDNA-cellulose (Cell Systems) for 1 hour at 4 °C with constant rotation. It was then transferred to a gravity column and subsequently washed with 10 CV Buffer A containing 500 mM NaCl. The RPA was eluted with 8 CV of Buffer A containing 1.5 M NaCl + 50% Ethylene Glycol. The elution was then diluted into a buffer containing 150 mM NaCl. The elute was subsequently loaded into a HiTrap Q column. The Q column was washed with wash buffers containing 150 mM NaCl. The protein was eluted using a gradient from 150 to 600 mM NaCl. SDS-PAGE was used to analyze protein bands, and the pure fractions were pooled and concentrated using Amicon Ultra 10 kDa MWCO centrifugal tubes (Millipore, USA) to obtain the final RPA protein complexes. Direct telomerase assay and quantification A standard base reaction (20 μl) consisted of dNTPs, 200 nM 5’ Phos-TTAGGGTTAGGGTTAGGG DNA primer (Integrated DNA Technologies, USA), and approximately 0.5 nM telomerase (quantified using TR dot blot) in the assay buffer containing 50 mM HEPES–NaOH (pH 7.5), 100 mM KCl, 5 mM MgCl2, and 2 mM DTT. Recombinant protein complexes and proteins were added to the reactions at concentrations specified in each figure legend. The reaction mixtures were pre-incubated at room temperature for 30 min, after which the enzymatic reactions were initiated by adding dNTPs. The dNTP mixture used was: 10 μM dGTP, 10 μM dTTP, 2.42 μM dATP, and 0.084 μM [α-³²P]dATP. The reactions were incubated at 37°C for 1 hour, then quenched with 5 M ammonium acetate and 200 μg/mL glycogen (Roche) for DNA precipitation. A radiolabeled 15-nt (TTAGGGTTAGGGTTA) oligonucleotide was added as a loading control in this step. After DNA precipitation, each sample was dissolved in 5 μl ultrapure water (Catalog #10977015, Invitrogen, USA) and 5 μl 2x formamide loading dye. 9 μL of each sample was loaded into each well of a 10% or 12% 1x TBE 7 M urea PAGE gel. Electrophoresis was performed at a constant 45 W until the bromophenol blue reached a third of the way up the gel. The gels were vacuum-dried at 80°C for 1 hour, then exposed to a storage phosphor screen. After exposure, the gels were imaged on an Amersham Typhoon gel imager (Cytiva, USA). Enzyme activity and repeat-addition processivity were quantified using GelAnalyzer software (version 23.11; www.gelanalyzer.com). Telomerase activity was determined by summing the signal intensities of all extension products and normalizing the sum to the loading control. Repeat addition processivity was calculated as the ratio of the cumulative signal from longer extension products (>+8 repeats) to that from shorter extension products (≤+8 repeats), as described previously [26]. Supporting information Characterization of telomere maintenance defects in ssb1 mutants isolated from a genetic screen. (A) Schematic diagram of the fission yeast telomere region. For Southern blot analysis, genomic DNA was digested with EcoRI and hybridized with a telomere repeat probe. The EcoRI site lies ~750 bp from the end of the telomeric repeat tract. Primers used in telomere ChIP qPCR (S4 Table) are also indicated. (B, C) Telomere length analysis by Southern blot of the indicated ssb1/rpa1 mutant strains. Mutant allele numbers are indicated (#), and relative Ssb1 protein expression levels, previously quantified by western blot [30], are shown. Mutants expressing less than 50% of wt Ssb1 are highlighted in red. (D) Plasmid-based complementation analysis: ssb1-W523C cells were transformed with plasmids carrying individual ssb1 point mutations and analyzed by Southern blot for telomere length. The original mutations addressed in this assay are indicated. Mutant plasmids that caused very short telomeres are highlighted in red. (E) Plasmid assay as in (D), using ssb1 mutant plasmids carrying mutations equivalent to those known to cause telomere shortening in human cells, indicated by an asterisk (*). (TIF) Additional data for ssb1 mutants with short telomeres. (A) Schematic representation of the fission yeast ssb1 locus, indicating the positions of the mutations. For integration selection purposes, the nmt1 3’ UTR and the kanamycin resistance marker kanMX were placed downstream of ssb1. (B) Telomere length analysis by Southern blot of the indicated ssb1 mutant strains. All strains were extensively restreaked to obtain terminal telomere phenotypes. These strains represent independently generated second-mutant clones of the mutants shown in Fig 1C. (C) Expression levels of single ssb1 mutant strains assessed by western blot analysis. Ssb1 was detected using an anti-Ssb1 antibody. A Ponceau-stained membrane is shown as loading control. Quantifications of relative Ssb1 protein expression levels to wt Ssb1 (set to 100%) are shown below. (D) Telomere length analysis by Southern blot of the indicated multiple independently obtained ssb1 mutant strains. All strains were extensively restreaked to obtain terminal telomere phenotypes. (E) ChIP analysis of Trt1-myc binding to telomeres in the indicated ssb1 mutant strains. Statistical significance was assessed by ANOVA with Dunnett’s comparison test (*P ≤ 0.05; ***P ≤ 0.001). See S1 Data for individual % IP values and additional statistical analysis. (F-H) Telomere length analysis by Southern blot of the indicated ssb1 mutants in tpz1+ (wt) or tpz1-K75A backgrounds after extensive restreaks. Multiple independent ssb1 tpz1-K75A double-mutant strains were analyzed. (TIF) Sequence alignments. (A-C) Sequence alignments with MUSCLE [95], generated using SnapGene for Ssb1/Rfa1/RPA1 (A), Ssb2/Rfa2/RPA2 (B), and Trt1/Est2/TERT (C). Residues discussed in this study are indicated. (D) Sequence alignment for the N-terminal domain of Tpz1/Est3/TPP1, adjusted based on AlphaFold3 structure models. TEL-patch residues, TELR residues, and their proposed interactions with other complex components within the RPA–TERT–TPP1-like complexes are indicated. (PDF) Further characterization of ssb1-W523C strains. (A) Five-fold serial dilutions of the indicated strains were plated onto YES medium with the indicated concentrations of MMS, HU, or CPT. Pictures were taken after 3 days at 32 °C. Earlier-generation ssb1-W523C strains with linear chromosomes were significantly less sensitive to drugs than the ssb1-W523C strain that has lost telomeres. Control strains sensitive to drugs (trt1∆ with circular chromosomes, rad3∆, and ssb1-D223Y) were also included. (B) Pictures of fluorescence Ssb3-GFP foci for the indicated strains overlayed with fission yeast cells. Scale bar represents 10 µm. (C) Quantification of the fraction of cells with Ssb3-GFP foci for the indicated strains. Statistical significance was assessed by ANOVA with Dunnett’s comparison test (**P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001). See S1 Data for individual % nuclei with foci values and additional statistical analysis. (TIF) Strategies for generating elongated telomere strain series. (A) Schematic diagram of the strategy used to generate elongated isogenic telomere series. For more details, see the Materials and Methods section. (B) Representative Southern blot analysis of a telomere-elongated strain series for trt1-D743C-myc. (C-E) Southern blots for parental strains used in rap1∆ x poz1∆ crosses to generate telomere-elongated strains. (TIF) AlphaFold3 prediction of the RPA–Trt1–Tpz1 complex. (A, B) Overlay of top-scoring AlphaFold3 models for the RPA–Trt1–Tpz1 complex, shown from two different viewpoints. (A) Overlay of models containing full-length RPA subunits (Ssb1, Ssb2, and Ssb3), full-length Trt1, and Tpz1(aa1–219). (B) Overlay of models containing trimmed RPA subunits (Ssb1 and Ssb2), full-length Ssb3 and Trt1, and Tpz1(aa1–155). (C) Superposition of the fission yeast AlphaFold3 model (left) with the Tetrahymena telomerase cryo-EM structure (center), shown individually and overlaid (right) in two orientations. (D) Detailed model of the interaction between Tpz1 TEL-patch residues K75 and E74 and Trt1-TEN-domain residues E143 and K145, respectively. Residues Tpz1-E116 and Trt1-S85, which may further stabilize this interface, are also indicated. (E) Detailed structure of the Ssb1–Trt1 interface. (TIF) Analysis of ssb2 and ssb3 mutants, and comparison between the RPA structure within the AlphaFold3 RPA–Trt1–Tpz1 model and the X-ray structure of the RPA–ssDNA complex. (A) Schematic representations of fission yeast Ssb2 truncation mutants lacking the WH domain and of Ssb3. Regions represented in the U. maydis X-ray structure are indicated. (B, C) Telomere length analysis by Southern blot of ssb2 truncation mutants (B) and ssb3∆ cells (C). (D) X-ray structure of U. maydis RPA bound to ssDNA [38], labeled using fission yeast nomenclature. DBD-A, -B, and -C of Ssb1, DBD-D of Ssb2, and OB-E of Ssb3 are indicated. Residues discussed in this study are marked. (E, F) Corresponding structures from the fission yeast AlphaFold3 model and U. maydis X-ray structure are shown individually and superimposed. (TIF) Additional data related to ssb2 and trt1 mutants. (A) Telomere length analysis by Southern blot of tpz1-R81E ssb2 double mutants in the presence (trt1+) or absence (trt1∆) of telomerase. Terminal telomere phenotypes were determined after extensive restreaking. (B, C) Telomere length analysis by Southern blot of the indicated ssb2 mutants affecting the Ssb2–Tpz1 (B) or the Ssb2–Trt1 (C) interfaces, each in combination with tpz1-K75A. Terminal telomere phenotypes were determined after extensive restreaking. (D) Western blot analysis of mutant ssb2-FLAG strains to verify expression levels. Ssb2 was detected with an anti-FLAG antibody, and tubulin served as a loading control. (E) ChIP analysis of Trt1-myc binding to telomeres in the indicated ssb2 mutant strains, with corresponding telomere length analysis of the strains used for ChIP. Statistical significance was assessed by ANOVA with Dunnett’s comparison test (*P ≤ 0.05). See S1 Data for individual % IP values and additional statistical analysis. (F) Telomere length analysis by Southern blot of the indicated trt1 mutant strains after extensive restreaking. Two independently derived clones were analyzed for each mutant. (G) Western blot analysis for mutant trt1-myc strains to verify expression levels. Trt1 was detected with an anti-myc antibody, and tubulin served as a loading control. (H) Telomere length analysis by Southern blot of the indicated trt1 mutants in tpz1+ (wt) or tpz1-K75A backgrounds. Two independent tpz1-K75A double-mutant strains were analyzed. Terminal telomere phenotypes were determined after extensive restreaking. (TIF) Suppressor analysis for ssb1-W523C and tpz1-R81E. (A-G) Telomere length analysis by Southern blot of the indicated fission yeast mutant strains. (TIF) Analysis of DNA damage sensitivity for rfa1-W533C strains. Ten-fold serial dilutions of the indicated strains were plated onto YPDA medium with the indicated concentrations of MMS, HU, or CPT. Damage-sensitive rad52∆ strain served as a control. Pictures were taken after 2 days at 30 °C. (TIF) AlphaFold3 prediction of the RPA–Est2–Est3 complex. (A) Overlay of top-scoring AlphaFold3 models for the budding yeast RPA–Est2–Est3 complex, shown from two different viewpoints. (B) Superposition of the fission yeast RPA–Trt1–Tpz1 complex with the budding yeast RPA-Est2-Est3 complex. (C) Superposition of the Tetrahymena Cryo-EM structure with the budding yeast RPA–Est2–Est3 complex. (D) Superposition of the budding yeast X-ray structure RPA–ssDNA with the budding yeast RPA–Est2–Est3 complex. (E) Superposition of the budding yeast cryo-EM structure of telomerase complex with the budding yeast RPA–Est2–Est3 complex. (F) Detailed structures of the Rfa1–Est2 interface. Five top-scoring AlphaFold3 models are shown individually (light frames) or superimposed (bold frame). (TIF) AlphaFold3 prediction of the RPA–TERT–TPP1 complex. (A) Overlay of the top-scoring AlphaFold3 models for the human RPA–TERT–TPP1 complex, shown from two different viewpoints. (B, C) Human RPA–TERT–TPP1 model from AlphaFold3, and Human TERT–TPP1 cryo-EM structure, and RPA–ssDNA X-ray structure from U. maydis, shown individually (B) or superimposed (C). (D) Detailed view of the predicted human D61RPA2–R220TPP1 interaction, supported by neighboring residues, together with K78TERT–E215TTP1 interactions. (E) Detailed view of the predicted TERT-G106/A107 interaction with RPA1-W528, stabilized by intramolecular TERT interactions involving E113, R132, and K78, as well as the TPP1-E215 interaction. TPP1 is omitted from this panel to help visualize the relevant interactions. (TIF) Comparison to RPA–TERT–TPP1-like complex models from budding yeast and humans. (A, B) Functionally important protein-protein interactions identified in the fission yeast RPA–Trt1–Tpz1 complex are conserved in budding yeast (A) and humans (B). Rfa1–Est2/RPA1–TERT interactions are shown in pink, Rfa2–Est2/RPA2–TERT in yellow, Rfa2–Est3/RPA2–TPP1 in blue, and Est2–Est3/TERT–TPP1 in green. Interacting sites are indicated. (C) Sequence alignments for Ssb2/Rfa2/RPA2 (left) and Tpz1/Est3/TPP1 (right). Interactions of individual residues with other complex partners are indicated. (TIF) Outputs from the AlphaFold3 server. (A) S. pombe Trt1-RPA-Tpz1. (B) S. cerevisiae Est2-RPA-Est3. (C) H. sapiens TERT-RPA-TPP1. (TIF) Fission yeast strains used in this study. (XLSX) Budding yeast strains used in this study. (XLSX) Plasmids used in this study. (XLSX) DNA primers used in this study. (XLSX) Source of various mutated and tagged alleles for fission yeast strains used in this study. (XLSX) Source data and statistical analysis for graphs in main and supplemental figures. (XLSX) Folder containing original AlphaFold3 Files for RPA-TERT-TPP1-like complexes from S. pombe, S. cerevisiae, and humans. (ZIP) Uncropped images for main and supplemental figures. (PDF) UCSF Chimera X file for S. pombe RPA-Trt1-Tpz1 complex. (CXS) UCSF Chimera X file for S. cerevisiae RPA-EST2-EST3 complex. (CXS) UCSF Chimera X file for human RPA-TERT-TPP1 complex. (CXS) A single file containing all supplemental figures S1-S14 and their legends. (PDF) Transfer Alert This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present. 13 Apr 2026 28 May 2026 PGENETICS-D-26-00361 Fission yeast RPA–TERT–Tpz1TPP1 complex promotes telomere extension and suppresses telomere recombination PLOS Genetics Dear Dr. Nakamura, Thank you for submitting your manuscript to PLOS Genetics. After careful consideration, we feel that it has merit but does not fully meet PLOS Genetics's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 27 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosgenetics@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgenetics/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Soni Lacefield, PhD Academic Editor PLOS Genetics Geraldine Butler Section Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics Additional Editor Comments: We thank you for your submission. Please be sure to respond to the reviewer's concerns and pay close attention to the requested statistical analyses. Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 1) We do not publish any copyright or trademark symbols that usually accompany proprietary names, eg ©, ®, or TM (e.g. next to drug or reagent names). Therefore please remove all instances of trademark/copyright symbols throughout the text, including: - ® on page: 32. 2) We have noticed that you have uploaded Supporting Information files, but you have not included a complete list of legends. Please add a full list of legends for your Supporting Information files after the references list. Reviewers' comments: Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: In the manuscript, Fission yeast RPA–TERT–Tpz1TPP1 complex promotes telomere extension and suppresses telomere recombination, the authors examine the role of the single-stranded DNA binding protein RPA in telomerase activation at fission yeast telomeres. While a role for RPA has been demonstrated in budding yeast and human cells, this manuscript is the first to characterize these interactions in fission yeast. The authors take advantage of AlphaFold 3 modeling combined with related experimental structures and existing genetic characterization across multiple species to propose interactions between the catalytic subunit of telomerase, the TPP1/Tpz1/Est3 protein, and the largest and second largest subunits of RPA that appear to facilitate telomerase action at telomeres. The authors present an analysis of an impressive number of mutants with characterization of telomere length, protein association with telomeres by ChIP, and expression levels. In some cases, reciprocal suppression and epistasis experiments support the proposed model. The work expands our understanding of interactions that regulate telomerase activity at telomeres and the analysis of similarities and differences between human telomerase and major model systems is useful and informative. While the experiments are extensive and the results are presented clearly, in some cases it is difficult to ascertain reproducibility and no statistical tests are presented to support claims. Additional quantification and attention to statistical significance is warranted. This is particularly true for the ChIP experiments since the analysis of Trt1 association with telomeric DNA underpins a major conclusion of the paper that the interactions analyzed primarily affect telomerase action and not recruitment. Major comments: 1. In cases where telomere length is measured, the number of times independent cultures were analyzed should be indicated (at least in cases where only a single sample is shown). Ideally, telomere length should be quantified to demonstrate reproducibility and the extent of the effect, particularly when the changes are subtle. 2. 142-144: Authors state, “Surprisingly, D235K led to a slight increase in telomere length.” Figure S1E. If there is an increase, it is very hard to discern given that the markers didn’t run the same amount on the two sides of the gel and these samples are in the middle (and the two colonies don’t look the same). This example illustrates why telomere lengths should be quantified throughout the manuscript. 3. The authors should state more clearly what the n values are for the ChIP experiments and what each point on the graph represents. It looks to me like there are often different numbers of points for different restreaks (Figure 2D-G). Why is that? I assume that the Southern blot is taken from one repeat? That should be stated. 4. ChIP assays require statistical analysis to support the statements made, with appropriate adjustment for multiple comparisons. 5. Why are the protein expression levels not quantified in S2B? Even with only 2 samples, it would be useful to have the quantification given. Minor comments: 1. In experiments like those shown in Figure 2D, it would be helpful to be clearer that the mutant trt1 protein is the Myc-tagged version that is being immunoprecipitated. As shown, the labeling seems to indicate that WT trt1-myc is being expressed in these cells. 2. In Figure 5, it would be very helpful to color code the different interactions to help the reader keep track. 3. 6E needs to be done additional times and statistical analysis done before claiming there is a difference. 4. Figure 6J: spiens rather than sapiens Reviewer #2: Recent studies have demonstrated that RPA activates telomerase in humans and budding yeast by interacting with TERT and TPP1 orthologs, indicating a direct role of RPA in its activation. In this study, Moser and colleagues used genetic and structural modelling to demonstrate the formation of a ternary RPA–Trt1–Tpz1 complex in fission yeast. This is interesting work that brings new insights into the mechanism underlying RPA-driven telomerase activation in the light of previous studies. However, some conclusions are sometimes reached without accounting for all possible hypotheses (e.g. for W523C mutant). A large number of mutants have been tested, which makes the reading difficult to follow. I would recommend to remove some data to lighten the study and to focus on the most interesting results that support the ternary RPA–Trt1–Tpz1 complex. I raised several points that should be addressed before publication. -Mutants L222A, D235K and T265A that are equivalent to mutation associated with telomeropathies in human have been tested in fission yeast. D235K led to a slight increase of telomere length (TL). Their interpretation is that gain of function of D235K increase RPA-Rad3 association. In contrast, the L222A which is also a gain of function mutant shows a modest shortening. Since the affinity for ssDNA have not been tested for L222A, D235K and T265A mutants, I will be cautious with the Rad3 interpretation that is contradicted by the L222A mutant. Moreover, the genetic analysis of these mutants adds little to the article’s main focus and can safely be omitted if not developed further. -“Chromatin immunoprecipitation (ChIP) assays for Trt1 detected moderate increases in telomere binding for all mutants except Y474N, which showed slightly reduced binding (Figs 1D and S2D). Thus, telomere shortening in these strains is unlikely to result from reduced telomerase recruitment and instead reflects impaired telomerase-mediated extension.” In figure 1D, telomerase recruitment has been tested in rpa1 mutants with short TL. I agree that telomerase seems to be recruited at a higher level than WT (although we miss statistical analysis here), however one possible explanation for this increase would be that telomeric replication stress provoked by Rpa1 mutations causes telomerase recruitment, since it has been shown that telomerase can be recruited at stalled or broken replication forks. This is particularly true for the W523C mutation for which the authors conclude that “Taken together, these results identify ssb1-W523C as a separation-of-function mutant that uncouples telomerase recruitment from telomerase activation.” According to the Alphafold model, this residue contacts ssDNA and previous published results from the Nakamura lab showed that this mutant strain is sensitive to replication stress (HU and MMS), indicating that this substitution highly likely affects ssDNA properties of RPA. (ssDNA binding assays and DNA 2D-gel electrophoresis might eventually be done to demonstrate the neutrality of this mutation). Thus, it seems to me that this mutant it clearly not a separation-of-function mutant. On the top of that, the equivalent mutation of W523C (RPA1-W528C in human) has a modest effect on telomerase processivity (Fig 6E). This mutation is somehow reminiscent to D223Y mutation that impairs ssDNA binding properties of RPA, cause sensitivity to DNA damaging agents and provokes the accumulation of RPA at telomeres. It is likely that the amount of RPA detected by ChIP at telomeres in this study reflects mainly the level of RPA recruited during replication at forks and not the level of RPA that act as telomerase-processivity factor, leading to a misinterpretation of the results. In addition, “A similar pattern was observed in the catalytically inactive trt1-D743A mutant (Fig 2E), indicating that ssb1-W523C cells are not defective in telomerase recruitment, but instead fail to engage in productive elongation of telomeres.” I don’t understand this conclusion. Comparing Fig 2D and 2E, it seems clear that Trt1-D734A exacerbates the shortening of telomeres, clearly indicating that W523C mutant shortens its telomeres not only because of a defect of telomerase activation In conclusion, I found the analysis of W523C mutant uncomplete and misinterpreted, burdening this work. I would recommend to focus the work on residues that alter Rpa1-Trt1 and Rpa2-Tr1t interactions. -line 253: tpz1-E74 instead of tpz1-K74? -Again, I advise caution in interpreting the Rpa2-W112A data, since this W112 contacts ssDNA. Overall, It is intriguing that ssDNA contact residues are also involved in Trt1 interaction. Does it reveal a change in the mode of binding of RPA to ssDNA to accommodate telomerase association. -Direct telomerase assay in Fig 6E showed that the equivalent mutation of W523C (RPA1-W528C) has a modest effect on telomerase processivity. Thus, it seems contradictory with the separation-of-function W523C mutant. Does the equivalent mutation of Rpa2-W112A has been tested by telomerase assay? -Budding yeast data doesn’t seem to bring more insights. This can be removed to lighten the work. - One aspect that is not discussed here is that RPA is mainly recruited at telomeres in S-phase than much earlier telomerase (shown by the Nakamura lab EMBO 2009). How does this fit with the model presented here? Again, a main concern here is that asynchronous ChIP of RPA at telomeres presented here reflects mainly the level of RPA recruited during S-phase and mask the amount of RPA that acts as a processivity factor for telomerase. Reviewer #3: In this manuscript, Moser and colleagues investigate the role of RPA in telomerase activity. Previous works in different model organisms suggested that RPA may regulate telomerase access and activity at telomeres, but the underlying molecular mechanisms remain to be investigated more closely, particularly in Schizosaccharomyces pombe. Using extensive genetic analyses and a structural modeling approach, the authors dissect the regulation of telomerase recruitment and activity by RPA and Tpz1. More specifically, they analyzed many separation-of-function mutants in RPA, Tpz1 and Trt1 for their ability to recruit telomerase or to maintain telomeres, and used AphaFold3 modeling to interpret the role of point mutants and guide the analyses of interaction interfaces. They propose a ternary RPA-Trt1-Tpz1 complex held together with multiple interfaces between RPA-Trt1, RP1-Tpz1, and Trt1-Tpz1 (through the TEL-patch). For example, they characterize the ssb1-W523C mutant capable of telomerase recruitment but not activity, since telomeres are not stably maintained, suggesting that RPA is important for telomerase activity. Finally, the authors provide some pieces of evidence in Saccharomyces cerevisiae and with human RPA, as well as structural modeling insights, to suggest the conservation of the regulation of telomerase by RPA. Overall, this work is excellent and the investigation very extensive and detailed, based on rigorous genetic analyses and convincing structural modeling interpretation. I have only a few minor comments, listed below: Line 77: It is not clear that the names of RPA subunits inside or outside the parentheses correspond to the human complex. Clarifying the names of the RPA subunits in the different mentioned organisms as early as possible would help. Line 142, “Surprisingly, D235K led to a slight increase in telomere length”: This is not obvious on the image, unless there is a quantitative analysis to support this result. Line 159, “Chromatin immunoprecipitation (ChIP) assays for Trt1”: Although the primers are mentioned in the method section, it could be useful to explain in the text which telomere/subtelomere is targeted by qPCR. Lines 169-170, “Multiple double mutant clones either lost telomeres completely or displayed subtelomeric rearrangements and telomere amplification”: How many generations or passages were needed to observe these rearrangements? Is this consistent with alternative maintenance pathways? Can the authors comment on the variability of the rearrangements? Fig. 2, especially E and F: The Southern blots could be better aligned vertically to the ChIP graphs for samples a to f, which are the most important. Lines 227-229: Could the authors provide metrics on the quality and confidence of the models (pLDDT for example). Lines 261-265: Do the authors envision the presence of RPA on the 3’ overhang at all phases of the cell cycle or only when the single-stranded DNA is long enough? Or do they think that RPA travels with the replication fork and interacts with Trt1 at the end of the S phase? The sources of single-stranded DNA are discussed in the Discussion section, but it might be useful to have a pointer to the discussion here to help the reader picturing the whole process. Lines 306-307, “In contrast, ssb2-W112A caused reduced telomere binding despite normal Ssb2 protein expression”: Ssb2-W112A appears to be more expressed than the wt. Lines 416-418: Could the authors speculate on the mechanisms by which RPA-Trt1, RPA-Tpz1 and Trt1-Tpz1 interactions inhibit recombination? Do they lock RPA on the single-stranded DNA, thus preventing Rad51 loading? Fig. 6B: Just based on these Southern blots, it is not clear whether the additional bands seen in the right-hand panel correspond to subtelomeric rearrangements as the authors state. They could correspond to telomere elongation, possibly telomerase-dependent or independent. Besides, it would be interesting to show the bands corresponding to Y’ elements, the intensity of which might reflect changes of Y’ element copy number. Discussion: I found the discussion somewhat lengthy and at times redundant with the results section. ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: No: I do not see data corresponding to the ChIP graphs in the supplement. Reviewer #2: Yes Reviewer #3: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Figure resubmission: While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix. After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols 27 Jul 2026 Submitted filename: Response to Reviewers.docx 19 Aug 2026 Dear Dr Nakamura, We are pleased to inform you that your manuscript entitled "Fission yeast RPA–TERT–Tpz1TPP1 complex promotes telomere extension and suppresses telomere recombination" has been editorially accepted for publication in PLOS Genetics. Congratulations! Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made. Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org. In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date. Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics! Yours sincerely, Soni Lacefield, PhD Academic Editor PLOS Genetics Geraldine Butler Section Editor PLOS Genetics Aimée Dudley Editor-in-Chief PLOS Genetics Anne Goriely Editor-in-Chief PLOS Genetics www.plosgenetics.org BlueSky: @plos.bsky.social ---------------------------------------------------- Comments from the reviewers (if applicable): Congratulations on the acceptance! We would like the authors to consider adding to the text to respond to reviewer 2's comments on potential alternative models for Rpa3-GFP associated with telomere shortening and the possibility that it may not be a complete separation of function allele. Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: The authors have addressed my concerns. I appreciate the extensive dataset provided (along with transparent statistical analysis) to support key findings in the manuscript. Reviewer #2: I appreciate the authors' efforts in addressing the comments and implementing the requested modifications to the manuscript, including the new figures. In Figure 1D, the authors assume that telomerase recruitment is equivalent to telomere elongation. Have they considered that telomerase might also play a protective role at telomeric DNA ends? In other words, detecting telomerase by ChIP does not necessarily indicate a failure to maintain telomere length, contrary to their conclusion. I still have concerns about the analysis of the W523C mutant. My reasoning was based on its sensitivity to HU and MMS (Figure 3B in Xu et al., 2023, Nakamura’s lab). However, the fact that the W523C strain in this previous study has likely circular chromosomes made the interpretation confusing. According to new figure S4A, I agree that W523C is less severe than D223Y. That said, the accumulation of Rpa3-GFP associated with telomere shortening is not definitive proof. One alternative explanation is that telomere shortening increases replication stress as demonstrated, leading to ssDNA accumulation and RPA recruitment. I would urge extreme caution when drawing conclusions about W523C as a true separation-of-function mutant. In my view, demonstrating a separation-of-function for this mutant requires direct confirmation of the ssDNA-binding properties of the mutated complex. Reviewer #3: The authors have addressed the few comments I had. Congratulations to them for the extensive work. ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ---------------------------------------------------- Data Deposition If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website. The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-26-00361R1 More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support. Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present. ---------------------------------------------------- Press Queries If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org. PGENETICS-D-26-00361R1 Fission yeast RPA–TERT–Tpz1TPP1 complex promotes telomere extension and suppresses telomere recombination Dear Dr Nakamura, We are pleased to inform you that your manuscript entitled "Fission yeast RPA–TERT–Tpz1TPP1 complex promotes telomere extension and suppresses telomere recombination" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work! With kind regards, Sharmila Kamatchi PLOS Genetics On behalf of: The PLOS Genetics Team Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom plosgenetics@plos.org | +44 (0) 1223-442823 plosgenetics.org | Twitter: @PLOSGenetics